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A B S T R A C T
Background
Infantile colic is typically defined as full-force crying for at least three hours per day, on at least three days per week, for at least three
weeks. This condition appears to be more frequent in the first six weeks of life (prevalence range of 17% to 25%), depending on the
specific location reported and definitions used, and it usually resolves by three months of age. The aetiopathogenesis of infantile colic
is unclear but most likely multifactorial. A number of psychological, behavioural and biological components (food hypersensitivity,
allergy or both; gut microflora and dysmotility) are thought to contribute to its manifestation. The role of diet as a component in
infantile colic remains controversial.
Objectives
To assess the effects of dietary modifications for reducing colic in infants less than four months of age.
Search methods
In July 2018 we searched CENTRAL, MEDLINE, Embase , 17 other databases and 2 trials registers. We also searched Google, checked
and handsearched references and contacted study authors.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs evaluating the effects of dietary modifications, alone or in combination, for
colicky infants younger than four months of age versus another intervention or placebo. We used specific definitions for colic, age of
onset and the methods for performing the intervention. We defined ’modified diet’ as any diet altered to include or exclude certain
components.
Data collection and analysis
We used standard methodological procedures expected by Cochrane. Our primary outcome was duration of crying, and secondary
outcomes were response to intervention, frequency of crying episodes, parental/family quality of life, infant sleep duration, parental
satisfaction and adverse effects.
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Main results
We included 15 RCTs involving 1121 infants (balanced numbers of boys and girls) aged 2 to 16 weeks. All studies were small and at
high risk of bias across multiple design factors (e.g. selection, attrition). The studies covered a wide range of dietary interventions, and
there was limited scope for meta-analysis. Using the GRADE approach, we assessed the quality of the evidence as very low.
Low-allergen maternal diet versus a diet containing known potential allergens: one study (90 infants) found that 35/47 (74%)
of infants responded to a low-allergen maternal diet, compared with 16/43 (37%) of infants on a diet containing known potential
allergens.
Low-allergen diet or soy milk formula versus dicyclomine hydrochloride: one study (120 infants) found that 10/15 (66.6%)
breastfed babies responded to dicyclomine hydrochloride, compared with 24/45 (53.3%) formula-fed babies. There was little difference
in response between breastfed babies whose mother changed their diet (10/16; 62.5%) and babies who received soy milk formula (29/
44; 65.9%).
Hydrolysed formula versus standard formula: two studies (64 infants) found no difference in duration of crying, reported as a
dichotomous outcome: risk ratio 2.03, 95% confidence interval (CI) 0.81 to 5.10; very low-quality evidence. The author of one study
confirmed there were no adverse effects. One study (43 infants) reported a greater reduction in crying time postintervention with
hydrolysed formula (104 min/d, 95% CI 55 to 155) than with standard formula (3 min/d, 95% CI −63 to 67).
Hydrolysed formula versus another hydrolysed formula: one study (22 infants) found that two types of hydrolysed formula were
equally effective in resolving symptoms for babies who commenced with standard formula (Alimentum reduced crying to 2.21 h/d
(standard deviation (SD) 0.40) and Nutramigen to 2.93 h/d (SD 0.70)).
Hydrolysed formula or dairy- and soy-free maternal diet versus addition of parental education or counselling: one study (21
infants) found that crying time decreased to 2.03 h/d (SD 1.03) in the hydrolysed or dairy- and soy-free group compared with 1.08 h/
d (SD 0.7) in the parent education or counselling group, nine days into the intervention.
Partially hydrolysed, lower lactose, whey-based formulae containing oligosaccharide versus standard formula with simethicone:
one study (267 infants) found that both groups experienced a decrease in colic episodes (secondary outcome) after seven days (partially
hydrolysed formula: from 5.99 episodes (SD 1.84) to 2.47 episodes (SD 1.94); standard formula: from 5.41 episodes (SD 1.88) to
3.72 episodes (SD 1.98)). After two weeks the difference between the two groups was significant (partially hydrolysed: 1.76 episodes
(SD 1.60); standard formula: 3.32 episodes (SD 2.06)). The study author confirmed there were no adverse effects.
Lactase enzyme supplementation versus placebo: three studies (138 infants) assessed this comparison, but none reported data
amenable to analysis for any outcome. There were no adverse effects in any of the studies.
Extract of Foeniculum vulgare, Matricariae recutita, and Melissa officinalis versus placebo: one study (93 infants) found that
average daily crying time was lower for infants given the extract (76.9 min/d (SD 23.5), than infants given placebo (169.9 min/d (SD
23.1), at the end of the one-week study. There were no adverse effects.
Soy protein-based formula versus standard cows’ milk protein-based formula: one study (19 infants) reported a mean crying time
of 12.7 h/week (SD 16.4) in the soy formula group versus 17.3 h/week (SD 6.9) in the standard cows’ milk group, and that 5/10 (50%)
responded in the soy formula group versus 0/9 (0%) in the standard cows’ milk group.
Soy protein formula with polysaccharide versus standard soy protein formula: one study (27 infants) assessed this comparison but
did not provide disaggregated data for the number of responders in each group after treatment.
No study reported on our secondary outcomes of parental or family quality of life, infant sleep duration per 24 h, or parental satisfaction.
Authors’ conclusions
Currently, evidence of the effectiveness of dietary modifications for the treatment of infantile colic is sparse and at significant risk of
bias. The few available studies had small sample sizes, and most had serious limitations. There were insufficient studies, thus limiting
the use of meta-analysis. Benefits reported for hydrolysed formulas were inconsistent.
Based on available evidence, we are unable to recommend any intervention. Future studies of single interventions, using clinically
significant outcome measures, and appropriate design and power are needed.
P L A I N L A N G U A G E S U M M A R Y
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Diet changes for infant colic
Review question
Do colicky infants show an improvement when breastfeeding mothers follow a low-allergen diet, or when formula-fed infants are fed
a special formula?
Background
Infantile colic is a common problem afflicting otherwise healthy infants in the first three months of life. It is characterised by episodes
of inconsolable crying lasting for longer than three hours per day, for more than three days a week, for at least three weeks.
It can be very distressing for parents.
Dietary changes, such as removing cows’ milk from a breastfeeding mother’s diet or switching formula-fed babies to a special soy-based
formula, might reduce the symptoms of colic.
Study characteristics
We found 15 randomised controlled trials, a type of study in which participants are randomly assigned to one of two or more treatment
groups, involving a total of 1121 babies with colic. The evidence is current to July 2018.
Infants (balanced between boys and girls) were less than three months of age.
Key results
Most studies reported data on a combination of outcomes: duration of crying, number of responders in each group after treatment (i.e.
those who experienced a decrease in daily crying), or frequency of crying episodes. No study reported on parental or family quality of
life, infant sleep or parental satisfaction. Six studies reported that there were no side effects as a result of the dietary changes.
Low-allergen diet
One study (90 infants) found that more breastfed infants responded to a low-allergen maternal diet than infants on a standard diet
containing known potential allergens.
One study (120 infants) found little difference in breastfed infants whose mothers were given a low-allergen diet (10/16, 62.5%) and
formula-fed babies who were given soy milk (29/44, 65.9%), but the researchers did find that breastfed babies responded more to
dicyclomine hydrochloride (a tablet for treating stomach spasms) than formula-fed babies.
Hydrolysed formula milk
Two studies (64 infants) found no difference in duration of crying between the hydrolysed (hypoallergenic) and standard cow’s milk
groups. Of these, one study (43 infants) reported a greater reduction in crying time at study end in infants who were given hydrolysed
milk.
A third study (22 infants) found that two types of hydrolysed formulas were equally effective in resolving symptoms of colic for babies
started on standard formula.
A fourth study (21 infants) reported that infants whose parents were given information and support experienced a more rapid reduction
in crying time than infants who were given a hydrolysed formula or dairy- and soy-free diet (within nine days).
A fifth study (267 infants) found that both partially hydrolysed formula with oligosaccharides (carbohydrates) and a standard formula
with simethicone (a drug for treating symptoms of gas) reduced colic episodes after seven days, but effects were greater in the hydrolysed
plus oligosaccharides group after two weeks.
Lactase enzyme supplementation
Three studies (138 infants) tested the effect of adding lactase (an enzyme which helps break down the lactose (sugar) in milk) to the
infants’ milk. The results were not presented in a form to allow analysis.
Fennel, chamomile and lemon balm extract
One study (93 infants) found that average daily crying time in breastfed babies reduced within one week of treatment with a fennel,
chamomile and lemon balm extract.
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Soy protein-based formula
One study (19 infants) found that, compared with cows’ milk formula, soy formula reduced crying time and increased the number of
responders. However, international guidance does not support the use of soy milk due to concerns that they can impact hormones in
babies, so these results are not relevant.
One study (27 infants) compared soy formula plus polysaccharide (carbohydrate) with soy formula alone but did not present results in
a form we could analyse.
Quality of the evidence
Many of the studies included only small numbers of participants and were of poor quality. We did not find evidence of effectiveness
for most dietary interventions. Where studies did report some benefit, this was not large enough to be meaningful.
Conclusons
Based on the available evidence, we are not able to recommend any of the dietary modifications assessed in this review.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Dietary interventions for infantile colic versus placebo or other interventions
Patient or population: infants with colic def ined by recognised criteria
Settings: outpat ient
Intervention: any dietary intervent ion to treat infant ile colic
Comparison: placebo or any other intervent ion
Outcomes Impacts Number of studiesa Quality of the evidence
(GRADE)
Duration of crying This was the most commonly reported
outcome, but studies did so in an ex-
tremely heterogenous manner due to mea-
surement tools used, as well as t ime and
f requency of determ inat ion. There was no
clear ef fect as regards the ef f icacy of any
of the agents under study for reducing the
durat ion of crying in af fected infants
We were able to conduct a meta-analysis
of 2 studies comparing extensively-hydrol-
ysed formula versus standard cows’ m ilk
formulas. We found no dif ference in res-
olut ion of colic (dichotomous outcome)
between the groups (risk rat io 2.03, 95%
conf idence interval 0.81 to 5.10), relat ing
to 16 resolut ions of colic in babies given
an extensively-hydrolysed formula versus
7 in babies given standard cows’ m ilk for-
mula. One study did not specif ically report
the durat ion of crying at complet ion, only
whether there was a posit ive or negat ive
result
Results f rom 3 individual studies found
that a hydrolysed formula, herbal drops
and soy protein-based formula may reduce
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crying t ime at study end (cont inuous out-
come). 1 study found no dif ference be-
tween 2 types of hydrolysed formulas
Number of responders in each group after
treatment
There were mixed ef fects as regards the
ef f icacy of the agents under study for im-
proving the number of responders. Results
f rom 2 individual studies showed that a
low-allergen maternal diet and a soy pro-
tein-based formula may increase the num-
ber of responders. However, another study
found no evidence in favour of a low-al-
lergen diet or soy-milk formula but did
f ind that dicyclomine hydrochloride may
increase the number of breastfed babies
who respond
3 ⊕©©©
Very lowb
Frequency of crying episodes per 24 h Results f rom 2 individual studies showed
that a hydrolysed or dairy- and soy-f ree
formula and a part ially hydrolysed for-
mula may reduce the f requency of crying
episodes per 24 h. As this is very dif f icult
to discern f rom normality and is not a key
component of infant ile colic diagnost ic cri-
teria or a necessary a goal of clinicians,
the clinical relevance of this outcome is
worth readers’ considerat ion
2 ⊕©©©
Very lowb
Parental or family quality of life, including
measures of parental stress, anxiety or
depression
No data
Infant sleep duration per 24 h at 7, 14 and
21 days from start of intervention
No data
Parental satisfaction No data
6
D
ie
ta
r
y
m
o
d
ifi
c
a
tio
n
s
fo
r
in
fa
n
tile
c
o
lic
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Adverse effects to dietary modifications This is a key outcome, given the populat ion
under study, which was poorly reported in
many studies. 3 studies reported that there
were no adverse ef fects. 3 authors (one
of whom is an author on this review) of
3 other studies conf irmed there were no
adverse ef fects. The 9 remaining studies
did not report on adverse ef fects
6 ⊕©©©
Very lowb
GRADE Working Group - grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aPart icipant numbers have not been included in the table as it contains mult iple comparisons.
bWe downgraded the quality of the evidence for all outcomes, across all studies, due to consistent issues with incomplete
outcome data, select ive report ing, the presence of extremely small sample sizes, drug and nutrit ion company involvement,
and risk of bias. These issues were pervasive across the evidence base and must be considered when interpret ing any of the
reported f indings.
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B A C K G R O U N D
The most frequently cited definition of infantile colic is the rule
of three: unexplained episodes of paroxysmal crying for longer
than three hours per day, for three days per week, for at least three
weeks (Wessel 1954).More recently, colic has been included under
functional gastrointestinal disorders (Rome IV diagnostic criteria),
and the definition has been expanded to include paroxysms of
irritability and fussiness for at least one week in an infant that has
no failure to thrive (Drossman 2016).
This condition appears to be more frequent in the first six weeks of
life, occurring in 17% to 25% of newborns, depending on geog-
raphy and definitions employed, with prevalence often peaking at
that point. It is important to note that without any intervention,
colic symptoms are usually below the threshold of such diagnos-
tic criteria by three months of age (Reijneveld 2001; Vandenplas
2015; Wolke 2017).
Description of the condition
Paroxysms of inconsolable crying due to colic are often accom-
panied by flushing of the face, meteorism (excessive flatulence in
the intestinal tract with distention of the abdomen), drawing-up
of the legs, and flatulence (Gupta 2007; Savino 2010). Symptoms
typically start in the second week of life in both breastfed and
formula-fed infants and usually resolve by three months of age
(Lucas 1998; Vandenplas 2017). Generally speaking, these symp-
toms are not indicative of disease and thus hospital admission for
these infants is generally unnecessary, detrimental and not to be
encouraged (Savino 2007). However, most understanding of the
condition is based on research that includes a cohort of children
whose parents have chosen to seek help, so it is worth noting that
this may not reflect the whole population, and what separates colic
from non-colic may simply be the parents’ decision to self-seek
care (further discussions on this point are outside of the scope of
this review). Furthermore, five per cent of colicky crying infants
do have a serious underlying medical problem (Freedman 2009;
Savino 2005; Savino 2007). Thus, clinicians should assess all col-
icky infants to rule out underlying medical conditions that require
investigation and treatment (Savino 2010).
The aetiopathogenesis of infantile colic remains undefined and is
most likely multifactorial. Despite the common nature of the con-
dition, there is a general paucity of evidence investigating this area.
Different authors have suggested that a number of behavioural
(psychological and social) and biological (food hypersensitivity or
allergy (or both) components (Clifford 2002); gut microflora and
dysmotility) factors can contribute to its manifestation (Camilleri
2017). These include the following.
First, lactose intolerance - due to a relative lactase deficiency - has
been postulated as a possible causative factor in infant colic. Car-
bohydrate malabsorption leads to colonic fermentation of sugars
and an increase in levels of hydrogen gas. The rapid production
of hydrogen in the lower bowel distends the colon, sometimes
causing pain, whereas the osmotic pressures generated by lactose
and lactic acid in the colon cause an influx of water, leading to
further distension of the bowel. Although studies evaluating the
degree of hydrogen in the breath of colicky infants have produced
inconsistent results, some studies have reported increases in breath
hydrogen levels (Hyams 1989; Miller 1990; Moore 1988).
Second, the immunological model of colic focuses on possible al-
lergens, such as cows’ milk proteins in breast milk or infant for-
mula, as the cause of colic. Intact proteins from the mother’s diet
are hypothesised to cross over into the breast milk and provoke
an allergic response and symptoms of colic in some infants. Con-
sequently, some authors have proposed a low-allergen maternal
diet as a form of treatment (Hill 2005; Schach 2002). Shannon
1921 was the first to raise the possibility that infantile colic could
be related to allergens. Since then, a number of studies have eval-
uated the possible association between colic and food hypersen-
sitivity (Campbell 1989; Estep 2000; Forsyth 1989; Hill 1995;
Hill 2005; Iacono 1991; Jakobsson 1983; Lindberg 1999; Lothe
1987; Lucassen 2000). Articles in favour of this hypothesis re-
port that about 25% of infants with moderate or severe symptoms
might have cows’ milk protein-dependent colic (Axelsson 1986;
Hill 2000; Lindberg 1999), which improves after some days of a
hypoallergenic diet (Campbell 1989; Dupont 2010; Estep 2000;
Iacono 1991; Iacono 2005; Jakobsson 1983; Jakobsson 2000;
Savino 2001). For these infants, infantile colic has been identified
as the first possible manifestation of atopic disease, and dietetic
treatment should be the first therapeutic approach (Gupta 2007;
Hall 2012; Perry 2011; Savino 2010). Indeed, dietary changes,
such as eliminating cows’ milk proteins, are particularly indicated
in cases of suspected intolerance to cows’ milk proteins (for exam-
ple, in infants with a positive family history; atopic disease such
as asthma, eczema and other immune disorders; onset after the
first month of life; and colic associated with other gastrointestinal
symptoms such as reflux, vomiting or diarrhoea) (Hill 1995; Hill
2005; Jakobsson 1983; Lucassen 2000).
Third, there is growing evidence that intestinal microbiota in col-
icky infants differ from those in healthy controls; research has
shown higher levels of anaerobic bacteria, such as coliform and Es-
cherichia coli, and a lower concentration of lactobacilli, in infants
with colic (Savino 2010).
Advances in molecular technologies utilising 16S ribosomal RNA
and ribosomal DNA created the opportunity for researchers to
index the intestinal microbial composition to better understand
its association with infantile colic. The researchers found that in-
fants who manifested symptoms of colic were colonised with sig-
nificantly higher levels of Proteobacteria and exhibited lower bac-
terial diversity when compared to their unaffected counterparts
(Dubois 2016). Additionally, colonisation levels of Actinobacteria
Bifidobacterium and Firmicute lactobacilli were inversely related
to the amount of crying and fussiness in newborns. (de Weerth
2013).
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A comparison of formula-fed infants with and without colic re-
vealed significant differences in total bacteria, Enterobacteriaceae
and faecal ammonia (Savino 2017).
Human milk naturally contains these prebiotics, defined as indi-
gestible oligosaccharides, which could selectively enhance the pro-
liferation of certain probiotic bacteria in the colon, especially Bifi-
dobacterium spp (Thomas 2010). Some studies have failed to find
a protective effect of breastfeeding on the development of colic in
breastfed infants (Clifford 2002). However, it is unclear whether
these studies compared infants who were exclusively breastfed
from birth versus infants who were exclusively formula-fed from
birth, so it is still unclear whether breastfeeding has some pro-
tective effect or whether artificial feeding compromises the infant
gut microbiome in some way. Oligosaccharide prebiotics (a mix-
ture of oligosaccharides (0.8 g/100 mL), comprising 90% galacto-
oligosaccharides and 10% fructo-oligosaccharides), may be effec-
tive treatments for crying in formula-fed infants with colic (Savino
2006; Vandenplas 2017; Vivatvakin 2010).
More recently, researchers exploring hypotheses and rationale for
causes of infantile colic have proposed three hypothetical mecha-
nisms that could potentially be involved in the aetiopathogenesis
of infantile colic: immaturity of bile acid mechanisms that alter
intraluminal and absorptive mechanisms, immaturity in motility,
and alterations in the microbiome (Camilleri 2017).
Description of the intervention
Dietarymodifications have often been suggested for both breastfed
and formula-fed infants with colic. We examined the following
dietary interventions.
Dietary modifications for breastfed, colicky infants who are aller-
gic to certain foods (cows’milk, wheat, eggs, soy, nuts, fish) involve
modifying the mother’s diet to exclude these components so the
infant receives a low-allergen maternal diet. A number of studies
have demonstrated a reduction in colic when breastfeeding moth-
ers consumed a hypoallergenic diet (Axelsson 1986; Clyne 1991;
Jakobsson 1983; Lothe 1990). For example, Hill 2005 demon-
strated that a monitored, low-allergen maternal diet, which ex-
cludes cows’ milk, eggs, peanuts, tree nuts, wheat, soy and fish,
leads to a reduction in distressed behaviour. Estep 2000 also pro-
posed a brief interruption of breastfeeding and a temporary sub-
stitution with an amino-acid-based formula; however, this inter-
vention could have negative effects on maternal-infant interaction
and on the longer term continuation of breastfeeding and should
only ever be considered as a last resort (Savino 2001; Savino 2007;
Savino 2010).
For formula-fed infants with colicky symptoms, dietary modifi-
cations involve decreasing or removing the intake of cows’ milk
from the infant’s diet, or changing the type of milk formula from
starting formulas to special formulas (hypoallergenic formula, soy
milk formula, whey hydrolysed formula, casein hydrolysed for-
mula, amino-acid based formula, partially hydrolysed formula,
low-lactose milk formula, formula with prebiotic, etc). Some trials
have used formulas containing partially hydrolysedwhey proteins,
low amounts of lactose, prebiotic oligosaccharides, and a high beta
palmitic acid content (Oggero 1994; Osborn 2013; Savino 2005;
Savino 2006). In formula-fed babies, where an underlying allergy
to cows’ milk protein is hypothesised to affect the infant, exten-
sively hydrolysed formulas, based on casein or whey, have been
shown to reduce colic symptoms (Cohen-Silver 2009; Forsyth
1989; Gupta 2007; Jakobsson 2000; Lucassen 2000). Other stud-
ies, hypothesising that malabsorption of lactose may lead to fuss-
ing and crying, have tested infant formulas with low-lactose con-
tent on the basis that this may reduce excess intestinal gas (Hyams
1989; Infante 2011; Moore 1988; Savino 2003).
Soy formulas may also reduce symptoms of colic in some formula-
fed infants. However, the European Society for Paediatric Gas-
troenterology, Hepatology and Nutrition (ESPGHAN) Commit-
tee on Nutrition stated recently that there is no evidence to sup-
port the use of soy formulas for managing colic. Additionally, due
to concerns regarding a cross-over allergy to cows’ milk protein
and their oestrogen content, such formulas should not be given
to infants with a food allergy during the first six months of life
(Agostoni 2006). As far back as 2004, the UK Chief Medical Of-
ficer advised against administering soy protein formula to infants
under 12 months of age.
Given the clinical and methodological heterogeneity of studies on
these interventions, the efficacy of these interventions in reducing
infant colic remains inconclusive at present.
How the intervention might work
Managing gut-related symptoms in infants can be challenging.
Many factors need to be taken into consideration, including ge-
ographical, psychological, behavioural, social and family environ-
ments, as well as the dietary approach taken to relieve symptoms
of infantile colic.
Many published studies have investigated dietary interventions
for reducing colic (Campbell 1989; Clifford 2002; Clyne 1991),
proposing a link between infant crying and the gastrointestinal
tract, thereby implicating the role of nutritional factors such as lac-
tose, lipids and cows’ milk proteins (Feinle-Bisset 2013; Jakobsson
1983; Jakobsson 2000; Lindberg 1999). Cows’ milk whey protein
elicits symptoms of infantile colic in colicky, formula-fed infants
(Lothe 1989). Intact proteins from the mother’s diet are hypoth-
esised to cross over into the breast milk and provoke an allergic
response and symptoms of colic in some infants (Axelsson 1986;
Clyne 1991).
There are several potential pathophysiological mechanisms which
could constitute a rational basis for the therapeutic use of di-
etary interventions, including immunomodulatory and anti-in-
flammatory actions, and effects on motility and pain perception
(Drossman 2016; Gupta 2007; Hill 2000).
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Different studies have proposed a possible role of nutrients in
the development of infantile colic; Nocerino 2012 investigated
potentially harmful metabolites, and Iacovou 2018 suggested that
a maternal low FODMAP (fermentable oligo-, di- and mono-
saccharides and polyols) diet may be associated with a reduction
of infant colic symptoms.
When exploring the causes of colic, we have to consider the possi-
bility that immaturity in hepatic synthesis, reduced levels of intra-
luminal bile acids and impaired ileal bile absorption of bile acids
result in malabsorption of fat and other nutrients. Alternatively,
the colonic flora may be abnormal, thereby resulting in increased
nutrient fermentations with harmful metabolites, or immaturity
of the enteric nervous systemmight lead to abnormal motility and
sensory functions of the intestine and colon (Camilleri 2017).
The growing body of evidence of gut dysfunction support the
possible role of nutrients and gut microbiota in the development
of infantile colic due to hypersensitivity and abnormal motility
(Gupta 2007; Heine 2008; Nocerino 2012). However, the exact
mechanisms by which cows’ milk and other food allergens induce
gastrointestinalmotility disorders need further investigation toun-
derstand the relationships of these symptoms to the diet (Camilleri
2017; Farré 2013;Heine 2006). Additional factors that could be at
play include oversensitivity to stimuli, whichmay predispose some
infants to irritability, fussing and increased crying (Farré 2013;
Keefe 1998; Savino 2007).
It is important to note that when all other pathologies have been
ruled out, the natural course of infantile colic is resolution; no
intervention is necessary. However, parents are often extremely
affected in a variety of ways by the symptoms of colic and seek
interventions frommultiple sources. This review is clearly situated
within the context of utility for such families. Indeed, parents of
infants with symptoms of colic who do not seek attention would
not be recruited for the studies likely to be found in any review of
treatments for infantile colic.
Why it is important to do this review
A number of studies and reviews of the evidence suggest that di-
etary interventions may be effective in reducing the symptoms
of colic in both breastfed and formula-fed infants (Cohen-Silver
2009; Garrison 2000; Hall 2012; Lucassen 2001; Perry 2011;
Savino 2010). Potential interventions have included a low-aller-
gen diet for mothers of breastfed infants (Hill 2005), hydrolysed
formulas (Forsyth 1989; Jakobsson 2000; Lucassen 2000), or low-
lactose content formulas for formula-fed infants (Infante 2011;
Savino 2003; Savino 2006). This systematic review examined the
effectiveness and safety of dietary modifications for infantile colic,
where possible distinguishing between breastfed and formula-fed
infants. Although there is a relatively recent systematic review on
this topic (Iacovou 2012), the search took place in 2010 and ex-
cluded all unpublished and grey literature. We have also used a
more recent review examining reported outcome measures within
infantile colic, Steutel 2014, to ensure that our review examines
an appropriate core outcome set (we consider this further within
the Discussion). An up-to-date systematic review using Cochrane
methodology was therefore required.
O B J E C T I V E S
To assess the effects of dietary modifications for reducing colic in
infants less than four months of age.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs.
Types of participants
Infants younger than four months of age suffering from infantile
colic (whether breastfed or formula-fed), as defined by the study.
Both breastfed and formula-fed infants were eligible.
Types of interventions
This review sought to compare any one of the following dietary
interventions, alone or in combination, versus another interven-
tion(s) or placebo.
Breastfed infants
1. An educational intervention that supports and directs a
specific dietary modification to modify the mother’s diet by
excluding certain components such as milk, yogurt, cheese and
other foods
2. Low-allergen maternal diet
3. Diet plan or dietary supplementation, regardless of
duration of intervention
Formula fed infants
1. Soy-based formula
2. Extensively hydrolysed formula based on whey or casein
3. Partially hydrolysed formula
4. Formula with low or no content of lactose
5. Amino-acid based formula
6. Formula that includes prebiotics
We excluded studies involving probiotics. For further information
on these interventions, please see Praveen 2014.
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Types of outcome measures
Primary outcomes
1. Duration of crying* (postintervention versus baseline).
Data could have been continuous (for example, hours per day),
or dichotomous (for example, reduction under a predefined
threshold, as determined by the study authors). Data must have
been collected prospectively, not through retrospective
recollection at the end of the study period, using methods such
as parent diaries, video or audio recordings, or actigraphy.
Secondary outcomes
1. Number of responders in each group after treatment*.
Responders were defined as those who experienced a decrease in
daily crying, as reported by the study authors (dichotomous
outcome).
2. Frequency of crying episodes per 24 h* (postintervention
versus baseline) (continuous outcome)
3. Parental or family quality of life, including measures of
parental stress, anxiety or depression* (continuous outcome)
4. Infant sleep duration per 24 h at 7, 14, and 21 days*
(postintervention versus baseline) (continuous outcome)
5. Parental satisfaction*, measured by Likert scales or a
numeric rating scale (continuous outcome)
6. Adverse effects to dietary modifications: constipation*,
vomiting*, diarrhoea, apnoea, apparent life-threatening events
and lethargy (dichotomous outcome). We analysed the frequency
of all adverse effects in each study group.
We included outcomes evaluated after the completion of any treat-
ment protocol (that is, any period, any number of treatments),
and also at later follow-up, when reported.
We used those outcomes indicated by an asterisk (*) to populate
the ’Summary of findings’ table for the main comparison, ’dietary
interventions for infantile colic versus placebo or other interven-
tions’, where data permitted.
Search methods for identification of studies
Electronic searches
We searched the databases and trials registers listed below up to
July 2018 using the strategies in Appendix 1. We imposed no
restrictions on publication date or language.
1. Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 6) in the Cochrane Library, which
includes the Cochrane Developmental, Psychosocial and
Learning Problems Specialised Register (searched 9 July 2018).
2. MEDLINE Ovid (1946 to June week 5 2018).
3. MEDLINE In-Process & Other Non-Indexed Citations
Ovid (searched 9 July 2018).
4. MEDLINE Epub Ahead of Print Ovid (searched 9 July
2018).
5. Embase Ovid (1974 to 2018 week 28).
6. CINAHL Plus EBSCOhost (Cumulative Index to Nursing
and Allied Health Literature; 1937 to 10 July 2018).
7. PsycINFO Ovid (1806 to July week 1 2018).
8. Science Citation Index Web of Science (SCI; 1970 to 10
July 2018).
9. Social Sciences Citation Index Web of Science (SSCI; 1970
to 10 July 2018).
10. Conference Proceedings Citation Index - Science Web of
Science (CPCI-S; 1990 to 10 July 2018).
11. Conference Proceedings Citation Index - Social Sciences &
Humanities Web of Science (CPCI-SS&H; 1990 to 10 July
2018).
12. Cochrane Database of Systematic Reviews (CDSR; 2018,
Issue 7), part of the Cochrane Library (searched 9 July 2018 ).
13. Database of Abstracts of Reviews of Effects (DARE; 2015,
Issue 2, Final issue), part of the Cochrane Library (searched 6
January 2016).
14. LILACS (Latin American and Caribbean Health Science
Information database; search.bvsalud.org/portal/?lang=en;
searched 10 July 2018).
15. IBECS (ibecs.isciii.es/cgi-bin/wxislind.exe/iah/online/?
IsisScript=iah/iah.xis&base=IBECS&lang=i&form=F; searched
10 July 2018).
16. HomeoIndex ( bases.bireme.br/cgi-bin/wxislind.exe/iah/
online/?IsisScript=iah/iah.xis&base=HomeoIndex&lang=i&
form=F; searched 10 July 2018).
17. Networked Digital Library of Theses and Dissertations
(NDLTD; www.ndltd.org; searched 10 July 2018).
18. TROVE (limited to Australian theses; trove.nla.gov.au;
searched 10 July 2018).
19. WorldCat (limited to theses; worldcat.org; searched 10 July
2018).
20. PubMed Dietary Supplement Subset ( ods.od.nih.gov/
Research/PubMed Dietary Supplement Subset.aspx; searched
10 July 2018).
21. ClinicalTrials.gov ( clinicaltrials.gov; searched 10 July
2018).
22. World Health Organization International Clinical Trials
Registry Platform (WHO ICTRP; apps.who.int/trialsearch;
searched 10 July 2018).
Searching other resources
We searched the bibliographies of included studies to identify any
other potentially relevant studies. On 9 July 2018, we searched
Google ( www.google.com) for grey literature, using the terms
’Infantile colic AND (diet OR formula) AND randomised con-
trolled trial’. We handsearched conference proceedings from the
ESPGHAN annual scientific meetings from the past five years
(from 2013 to 2018) to identify other potentially relevant stud-
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ies that may not be published in full. Where we identified ref-
erences to relevant unpublished or ongoing studies, we recorded
them and made attempts to obtain sufficient information so as to
incorporate them in the review. Where data were not complete,
we contacted the study authors in order to verify the eligibility of
the study.
Data collection and analysis
Selection of studies
Two reviewers (SB and MG) independently screened titles, ab-
stracts, and full reports for eligibility against the inclusion criteria
(see Criteria for considering studies for this review). Specifically,
they:
1. merged search results using reference management software
and removed duplicate records of the same report;
2. examined titles and abstracts to remove irrelevant reports;
3. retrieved full texts of potentially relevant reports;
4. linked together multiple reports of the same study;
5. examined full-text reports for studies that met the eligibility
criteria;
6. corresponded with investigators, when appropriate, to
clarify study eligibility;
7. at all stages, noted reasons for inclusion and exclusion of
reports, resolving any disagreements through consensus;
8. made final decisions on study inclusions and resolved any
discrepancies through a process of consensus;
9. proceeded to data collection.
As Pitkin 1999 discusses, there are issues of the accuracy with
which abstracts reflect the published report, so although we
searched conference abstracts for possible studies to include, we
excluded stand-alone abstract publications from our review; that
is, we only included abstract publications that related to a study
for which we also had a full-text report. See Differences between
protocol and review.
We recorded the outcomes of our decisions in a PRISMA diagram
(Moher 2009). See Figure 1.
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Figure 1. Study flow diagram.
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Data extraction and management
We developed data extraction forms a priori, as per the recom-
mendations in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011a). We then extracted, where possible,
information on the following.
1. Characteristics of participants: source of participants,
inclusion and exclusion criteria, total number at baseline, total
number at completion, setting, definition of ’colic’ applied,
diagnostic criteria applied, type of feeding (breastfeeding,
formula feeding), age at onset of colic, age at commencement of
intervention, and potential effect modifiers such as sex.
2. Interventions and controls: number of groups,
intervention(s) applied, frequency and duration of treatment,
total number of treatments, and concomitant use of pacifier.
3. Methods: study design, duration, sequence generation,
allocation concealment, blinding of outcome assessors, and
evaluation of success of blinding.
4. Outcomes: list of outcomes assessed, definitions used, and
values of means and standard deviations at baseline and at time
points defined by the study protocol (or change from baseline
measures, if given).
5. Results: outcome measures, follow-up data (including
means and standard deviations, standard errors, or confidence
intervals (CI) for continuous data, and summary tables for
dichotomous data), withdrawals, and losses to follow-up.
6. Other: references to other relevant studies, points to follow-
up with study authors, comments from the study authors, key
conclusions from the study (by the study authors), other
comments from the review authors.
Two review authors (SB; MG) extracted the data independently
using the data extraction form. A third review author (FS) resolved
any persisting disagreements, which occurred on two occasions.
We collated the data in the latest version of Review Manager 5
(RevMan 5) (RevMan 2014).
Assessment of risk of bias in included studies
Using the criteria recommended in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2017), two review au-
thors (SB;MG) independently evaluated each study for risk of bias
within each of the following domains: sequence generation; allo-
cation concealment; blinding of parents and health professionals;
blinding of outcome assessors; incomplete outcome data; selective
outcome reporting; and other potential threats to validity, which
included consideration of potential risks due to changing meth-
ods of data collection (such as different ways of recording crying).
They judged each domain as being at low, high, or unclear risk
of bias using the criteria described in Appendix 2, compared the
judgments, and discussed and resolved any inconsistencies in their
assessments. A third review author (FS) was available to resolve
any persisting disagreements, had there been any.
Measures of treatment effect
Dichotomous data
We present dichotomous outcome data as risk ratios (RR), since
the effects of the RR are readily understood (Walter 2000). We
report all outcome data with their associated 95%CIs and P values
(where possible). Using control event risks from the included trials,
we calculated the number needed to treat to benefit (NNTB)
and its associated 95% CI for statistically significant dichotomous
outcomes.
Continuous data
If all studies used the same measurement scale, we calculated
the mean difference (MD) for change scores. Where studies used
different scales, we calculated the standardised mean difference
(SMD) using Hedges’ g. Where necessary, we calculated effect es-
timates from P values, t statistics, analysis of variance (ANOVA)
tables or other statistics, as recommended in the Cochrane Hand-
book for Systematic Reviews of Interventions (Deeks 2017).
See alsoDifferences betweenprotocol and review andSavino 2014.
Unit of analysis issues
For each included study, we determined whether the unit of analy-
sis was appropriate for the unit of randomisation and the design of
that study (that is, whether the number of observations matched
the number of units that were randomised (Deeks 2017).
Studies with multiple treatment arms
In our primary analyses, we combined data across all eligible in-
tervention arms (dietary change, i.e. special formula) and com-
pared them with the combined results across all eligible control
arms (another intervention(s) or placebo), making single, pair-
wise comparisons.
Cross-over studies
In randomised cross-over studies, individuals receive each inter-
vention sequentially, in a random order. Cross-over studies usually
contain a washout period, which is a stage after the first treatment
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but before the second treatment, where time is given for the ac-
tive effects of the first treatment to wear off before the new treat-
ment begins in order to reduce the carry-over effect (when the first
treatment affects the second). Inadequate washouts are seen when
carry-over effects persist after the washout period. In this review,
we found both cross-over trials that did not provide an adequate
washout period and cross-over trials that provided separate data
for the first arm.
See Differences between protocol and review and Savino 2014.
Dealing with missing data
Where data were missing, we contacted the corresponding authors
of included studies, requesting them to supply any unreported
data. For all outcomes in all studies, we carried out analyses as far
as possible on an intention-to-treat basis; that is, we attempted to
include all participants randomised to each group in the analyses,
and we analysed all participants in the group to which they were
allocated regardless of whether or not they received the allocated
intervention. For missing continuous data, we estimated standard
deviations from other available data, such as standard errors, or
imputed them using the methods suggested in Higgins 2011b.
For loss to follow-up for continuous data, we based analyses on
those participants completing the trial, essentially assuming that
outcomewas the same in themissing participants and the observed
participants. Where there was a discrepancy between the number
randomised and the number analysed in each treatment group,
we calculated and reported the percentage lost to follow-up in
each group, where possible. Where it was not possible to obtain
the missing data, we recorded this on the data collection form,
reported it in the ’Risk of Bias’ table, and discussed the extent to
which the missing data might have altered the results and, hence,
the conclusions of the review. For included studies, we noted levels
of attrition.We explored the impact of including studies with high
levels of missing data in the overall assessment of treatment effect
by conducting sensitivity analyses (see Sensitivity analysis).
Assessment of heterogeneity
We assessed clinical and methodological heterogeneity by com-
paring the distribution of important participant characteristics be-
tween trials (age or presence of prematurity, length of symptoms
at recruitment) and trial characteristics (randomisation, conceal-
ment, blinding of outcome assessment, losses to follow-up, treat-
ment type, cointerventions).
We assessed statistical heterogeneity by examining the I2 statistic
(Deeks 2017), a quantity that describes the proportion of variation
in point estimates that is due to variability across studies rather
than sampling error.We interpreted the I2 statistic as suggested in
the latest version of the Cochrane Handbook for Systematic Reviews
of Interventions (Deeks 2017).
1. 0% to 40%: might not be important.
2. 30% to 60%: may represent moderate heterogeneity.
3. 50% to 90%: may represent substantial heterogeneity.
4. 75% to 100%: considerable heterogeneity.
We also evaluated the CI for the I2 statistic. In addition, we em-
ployed a Chi2 test of homogeneity, with a 10% level of signifi-
cance, to determine the strength of the evidence that the hetero-
geneity was genuine.
Assessment of reporting biases
In order to minimise publication bias, we attempted to obtain the
results of any unpublished studies, to compare the results extracted
from published journal reports with the results obtained from
other sources (including any correspondence).
Data synthesis
Where interventions were similar in terms of type of dietary mod-
ification, type of outcome assessed and type of colic, we grouped
studies and synthesised their results in a meta-analysis. Because
we assumed that clinical heterogeneity was very likely to impact
on our results, given the wide breadth and types of interventions
included, we combined studies using a random-effects model, ir-
respective of statistical evidence of heterogeneity. We calculated
all overall effects using inverse variance methods and carried out
statistical analysis using RevMan 5 (RevMan 2014). Where data
were insufficient, we provided a narrative description of the re-
sults.
Subgroup analysis and investigation of heterogeneity
Large numbers of subgroup analyses may lead to misleading con-
clusions (Oxman 1992; Yusuf 1991).We conducted the following
subgroup analyses, where possible.
1. Age of mother at time of birth (21 years and younger versus
older than 21 years).
2. Type of feeding (formula-fed versus breastfed).
3. Atopy (lower versus higher risk of atopy).
4. Follow-up (less than four weeks of treatment versus more
than four weeks of treatment).
5. Trial quality (low quality (lack of allocation concealment or
lack of blinding) versus high quality (allocation concealment and
blinding)).
Sensitivity analysis
We planned to conduct sensitivity analyses to determine whether
findings were sensitive to restricting the analyses to studies judged
to be at low risk of bias for blinded assessment of the primary out-
come. In addition, we planned to assess the sensitivity of findings
to any imputed data, by calculating the treatment effect includ-
ing and excluding the imputed data, to see whether this altered
the outcome of the analysis. We planned to investigate the effect
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of dropouts and exclusions by conducting worst- versus best-case
scenario analyses. We also analysed the effect of using the stringent
Wessel 1954 definition of infant colic, the more recent definition
given by Drossman 2016 and other variants.
Summary of findings table
We assessed the overall quality of the evidence for the following
outcomes measured at postintervention using the GRADE ap-
proach (Guyatt 2008): duration of crying; number of responders
in each group after treatment; frequency of crying episodes per 24
h; parental or family quality of life, including measures of parental
stress, anxiety or depression; infant sleep duration per 24 h at 7,
14, and 21 days; parental satisfaction; and adverse effects to dietary
modifications: constipation and vomiting. TheGRADE approach
appraises the quality of evidence based on the extent to which one
can be confident that an estimate of effect, or association, reflects
the item being assessed. RCTs start as high-quality evidence, but
may be downgraded due to: risk of bias (methodological quality),
indirectness of evidence, unexplained heterogeneity, imprecision
(sparse data), and publication bias. We determined the overall
quality of the evidence for each outcome after considering each of
these factors, and graded them as follows.
1. High quality: we are very confident that the true effect lies
close to that of the estimate of the effect.
2. Moderate quality: we are moderately confident in the effect
estimate: the true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
3. Low quality: our confidence in the effect estimate is
limited: the true effect may be substantially different from the
estimate of the effect.
4. Very low quality: we have very little confidence in the effect
estimate: the true effect is likely to be substantially different from
the estimate of effect.
We reported our quality ratings in a ’Summary of findings’ table,
whichwe constructed usingGRADEproGDT(GRADEproGDT
2015), for the comparison, ’dietary interventions for infantile colic
versus placebo or other interventions’.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies and Characteristics of ongoing studies.
Results of the search
Our electronic searches yielded 5486 records up to 10 July 2018;
we found two additional records from searching other sources.
After removing duplicates, two review authors independently
screened 3575 titles and abstracts for relevance, excluding 3526.
Of the 49 records brought forward for full-text review, we ex-
cluded 29 records reporting on 28 studies (Characteristics of
excluded studies), and included 17 records reporting on 15 studies
(Characteristics of included studies). The three remaining reports
relate to three ongoing studies (Characteristics of ongoing studies).
See Figure 1.
Included studies
This review includes 15 studies involving a total of 1121 par-
ticipants (Campbell 1989; Forsyth 1989; Hill 1995; Hill 2005;
Jakobsson 2000; Kanabar 2001; Kearney 1998; Lothe 1987;
Lucassen 2000; Miller 1990; Oggero 1994; Savino 2005; Savino
2006; Taubman 1988; Treem 1991). See Characteristics of
included studies tables.
Study design
All 15 studies were RCTs, and of these, seven used a cross-over
design (Forsyth 1989; Jakobsson 2000; Kanabar 2001; Kearney
1998; Lothe 1987; Miller 1990; Treem 1991).
Setting
Three studies took place in Turin, Italy (Oggero 1994; Savino
2005; Savino 2006), while two apiece were in Connecticut, USA (
Forsyth 1989; Treem1991);Melbourne, Australia (Hill 1995;Hill
2005); and Malmö, Sweden (Jakobsson 2000; Lothe 1987). One
study took place in Amsterdam, Netherlands (Lucassen 2000);
Cork, Ireland (Kearney 1998); London, UK (Kanabar 2001);
Pennsylvania, USA (Taubman 1988); Scotland, UK (Campbell
1989); and Sydney, Australia (Miller 1990).
Participants were recruited from outpatient services.
Participants
The age of participants ranged from 2 weeks in Hill 2005 to 16
weeks in Hill 1995.
Participants were diagnosed with colic on enrolment. The specific
criteria for a diagnosis of colic varied between studies, as did the
minimum length of symptoms required to make a diagnosis of
infantile colic. Most studies (87.5%) used a definition of colic
consistent with the Wessel criteria (Wessel 1954).
The studies excluded children with organic causes for their pathol-
ogy (see Characteristics of included studies tables).
Interventions
The duration of initial dietary intervention varied from 4 days in
Forsyth 1989 to 21 days in Savino 2005.
16Dietary modifications for infantile colic (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
The dietary modifications included: changes to the maternal diet
(Hill 1995; Hill 2005; Oggero 1994); extensively hydrolysed for-
mula (Forsyth 1989; Hill 1995; Jakobsson 2000; Lucassen 2000;
Taubman 1988); a partially hydrolysed, lower lactose, whey-based
formula with oligosaccharide (Savino 2006); the use of sime-
thicone (Savino 2006); addition of lactase enzyme to the infant’s
standard milk (Kanabar 2001; Kearney 1998; Miller 1990); phy-
totherapeutic agents (Savino 2005); soy formula (Campbell 1989;
Lothe 1987); or soy formula with polysaccharide (Treem 1991).
Outcomes
There was significant heterogeneity in the reporting of all out-
comes that limited almost all scope for meta-analysis. Below,
we present the key outcomes that studies reported, as shown in
Summary of findings for the main comparison.
1. Duration of crying (Campbell 1989; Forsyth 1989;
Lucassen 2000; Jakobsson 2000; Oggero 1994; Savino 2005).
2. Number of responders in each group after treatment
(Campbell 1989; Hill 2005; Oggero 1994).
3. Frequency of crying episodes per 24 h (Taubman 1988;
Savino 2006).
4. Adverse effects (Kanabar 2001; Kearney 1998; Lucassen
2000; Miller 1990; Savino 2005; Savino 2006).
Funding
Four studies reported public funding and stated that there had
been no financial involvement with industry (Campbell 1989;
Jakobsson 2000; Oggero 1994; Savino 2005). The manufactur-
ing companies of the study intervention sponsored three stud-
ies, but the study authors confirmed via email that industry had
no involvement in the conduct of the studies or the writing up
of the results (Lucassen 2000; Miller 1990; Savino 2006). The
manufacturers of the intervention supported eight studies in some
way (Forsyth 1989; Hill 1995; Hill 2005; Kanabar 2001; Kearney
1998; Lothe 1987; Taubman 1988; Treem 1991).
Excluded studies
We excluded 28 studies for various reasons, as summarised below.
1. Nine studies were not RCTs or quasi-RCTs (Arikan 2008;
Bellaiche 2018; Evans 1981; Iacono 1991; Imanieh 2004;
Jakobsson 1983; Nocerino 2012; Savilahti 1989; Xinias 2017).
2. Five studies were protocols for future research, letters in
journals or narrative review articles (Buchanan 1998; Gerrard
1984; Koonce 2011; Laws 1991; Sargsyan 2006).
3. Eleven studies did not select participating infants who were
suffering colic before the study but included normal infants
(Barr 1991; Berseth 2009; Campeotto 2011; Giovannini 2014;
Iacovou 2018; Infante 2011; Rozé 2012; Savino 2003; Sherman
2015; Vandenplas 2017; Vivatvakin 2010). As this is a review of
treating established colic, we excluded such studies.
4. Two studies were not of dietary modification, but of lactose
and cows’ milk protein allergy testing in colicky babies (Liebman
1981; Pärtty 2015).
5. One study was of probiotics (Dupont 2010).
Ongoing studies
There are three ongoing studies, which are all double-blind RCTs.
NCT01721850 is in healthy infants of 35 to 42 weeks gestational
age and 15 to 60 days old, with aWessel diagnosis of colic (Wessel
1954). There will be a parallel assignment with three arms: con-
trol formula (standard formula), intervention formula one (infant
formula with hydrolysed protein (type I) and pre- and probiotics),
intervention formula two (infant formula with hydrolysed protein
(type II) and pre- and probiotics).
NCT02813772 is enrolling full-term infants with a diagnosis of
“1Caccording toRome III criteria” (quote). Therewill be a parallel
assignment: a partially hydrolysed formula with reduced lactose
content andLactobacillus reuteri versus a standard formula.
NCT03329222 is enrolling full-term infants diagnosed with colic
and comparing a standard formula versus hydrolysed formula.
Risk of bias in included studies
Please see the ’Risk of bias’ tables, beneath the Characteristics of
included studies tables, for more information of the risk of bias
in the included studies. Please also see Figure 2 and Figure 3 for a
graphic summary of the risk of bias in the included studies.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generation
We considered nine studies to be at low risk of selection bias
based on the published report (Forsyth 1989; Jakobsson 2000;
Kanabar 2001; Kearney 1998; Oggero 1994; Savino 2005; Savino
2006; Taubman 1988; Treem 1991). In Lucassen 2000, the lead
author responded to a request formore information and confirmed
adequate sequence generation. The five remaining studies did not
describe the method of randomisation, so we judged these studies
to be at unclear risk of selection bias for this domain (Campbell
1989; Hill 1995; Hill 2005; Lothe 1987; Miller 1990).
Allocation concealment
We rated five studies at low risk of bias: four studies adequately de-
scribed allocation (Forsyth 1989; Hill 1995; Savino 2005; Savino
2006), and the lead author of one study, Lucassen 2000, responded
to a request for more information and confirmed adequate allo-
cation concealment. We judged the 10 remaining studies to be
at high risk of bias because the allocation concealment was not
reported (Campbell 1989; Hill 2005; Jakobsson 2000; Kanabar
2001; Kearney 1998; Lothe 1987; Miller 1990; Oggero 1994;
Taubman 1988; Treem 1991).
Blinding
Performance bias
We rated nine studies to be at low risk of performance bias
(Campbell 1989; Hill 1995; Kanabar 2001; Kearney 1998; Lothe
1987; Miller 1990; Lucassen 2000; Savino 2005; Treem 1991).
Authors of eight of these studies described adequate methods for
blinding participants and personnel (Campbell 1989; Hill 1995;
Kanabar 2001; Kearney 1998; Lothe 1987; Miller 1990; Savino
2005;Treem1991), while for Lucassen 2000, again the lead author
responded to a request for more information and confirmed ade-
quate blinding of participants and personnel. One study reported
the use of blinding but did not describe it clearly (Forsyth 1989),
so we rated it at unclear risk of performance bias. We rated five
studies at high risk of performance bias; four because they did not
adequately describe blinding of participants and personnel (Hill
2005; Jakobsson 2000; Oggero 1994; Taubman 1988), and one,
Savino 2006, because it was impossible to blind participants ow-
ing to the nature of the intervention and the control (simethicone
had to be administered to the infant separately).
Detection bias
We rated six studies at low risk of detection bias (Campbell
1989; Lothe 1987; Lucassen 2000; Miller 1990; Savino 2005;
Savino 2006). Five of these studies described adequate methods
for blinding of outcome assessment (Campbell 1989; Lothe 1987;
Miller 1990; Savino 2005; Savino 2006), while the lead author of
Lucassen 2000 confirmed adequate blinding by correspondence.
Five studies reported the use of blinding but did not describe it
clearly, so we judged these studies to be at unclear risk of detec-
tion bias (Forsyth 1989; Hill 1995; Kanabar 2001; Kearney 1998;
Treem 1991). We rated four studies at high risk of detection bias
because they did not describe blinding of outcome assessment
adequately (Hill 2005; Jakobsson 2000; Oggero 1994; Taubman
1988).
Incomplete outcome data
We judged two studies to be at high risk of attrition bias because
the details of dropouts were not clear from the report, and there
was only partial information as to which group they were from
(Forsyth 1989; Lothe 1987). Whilst some inference for an inten-
tion-to-treat analysis is possible, further details were not available
from the study authors. We rated four studies at unclear risk of
attrition bias because they did not adequately describe dropouts
(Jakobsson 2000; Kanabar 2001; Kearney 1998; Taubman 1988).
We judged the remaining nine studies to be at low risk of attrition
bias because dropouts were balanced across treatment groups, with
similar reasons for withdrawal and few dropouts (Campbell 1989;
Hill 1995; Hill 2005; Lucassen 2000; Miller 1990; Oggero 1994;
Savino 2005; Savino 2006; Treem 1991).
Selective reporting
We rated nine studies to be at high risk of reporting bias, as the
study authors did not report at all on adverse effects or did not
supply us with the information (Campbell 1989; Forsyth 1989;
Hill 1995; Hill 2005; Jakobsson 2000; Lothe 1987; Oggero 1994;
Taubman 1988; Treem1991).We judged the remaining six studies
to be at low risk of reporting bias, either because it was specifically
stated in the report of the study that there were no adverse effects
(Kanabar 2001; Kearney 1998; Savino 2005) or the study authors
confirmed that thiswas the case through correspondence (Lucassen
2000; Miller 1990; Savino 2006).
Other potential sources of bias
Because of the nature of the evidence contained within these stud-
ies, and the claims for one product or intervention over another
in such a vulnerable population, we considered any involvement
20Dietary modifications for infantile colic (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
by the companies supplying or manufacturing the intervention
product in the conduct of the studies or the writing up of results
to trigger a rating of high risk of other bias.
We considered four studies that stated no financial involvement
with industry, whether by provision of experimental product or
direct financial support for the work, to be at low risk of bias
(Campbell 1989; Jakobsson 2000; Oggero 1994; Savino 2005).
We judged a further three studies to be at unclear risk of bias as
they were sponsored by the manufacturing companies of the study
intervention, but we received confirmation that industry had no
involvement in the conduct of the studies or the writing up of
the results (Lucassen 2000; Miller 1990; Savino 2006). We rated
the remaining eight studies at high risk of bias as they stated that
they were supported in some way by the manufacturers of the
intervention or related products (Forsyth 1989; Hill 1995; Hill
2005; Kanabar 2001; Kearney 1998; Lothe 1987; Taubman 1988;
Treem 1991).
None of the studies appeared to have any other potential sources
of bias other than industry funding.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings: dietary interventions for infantile colic versus placebo
or other interventions
Below, we present the results for each combination of dietary reg-
imen and comparison, by assessed outcome and colic type, with
the exception of those studies for which we could not extract data.
Despite the significant number of studies, there was very limited
scope for any form of meta-analysis due to a combination of het-
erogenous outcome measures, grouping of different populations
in reports of results, and lack of reporting on key outcomes (in
particular, adverse effects) and summary outcome statistics. Thus,
in most cases, we provide a narrative description of the results. We
report exact P values, where available, from the primary studies;
where these were not available, we reported the figure given. We
report the GRADE rating throughout. However, as the same two
key issues affect all studies (imprecision due to very small sam-
ple sizes and risk of bias across all criteria), we do not make spe-
cial mention of these within each comparison. See Summary of
findings for the main comparison.
1. Low-allergen maternal diet versus a diet containing
known potential allergens
Two studies by the same team in Australia, with 205 infants in to-
tal, examined the effect of modifying breastfeeding mothers’ diets
to control for proteins or other substances that might be triggering
symptoms of colic (Hill 1995; Hill 2005). However, we were un-
able to combine the data from these studies in a meta-analysis be-
cause Hill 1995 grouped together breastfed babies whose mothers’
diets were modified and formula-fed babies whose own diet was
modified to remove the proteins. Authors did not report separate
data for breastfeeding mothers only, and the study authors did not
respond to our request for these data.
Primary outcome: duration of crying
Neither study reported data on this outcome (Hill 1995; Hill
2005).
Secondary outcomes: number of responders in each group
after treatment
Hill 2005 (90 infants) reported a significant difference (P <0.01) in
responders (i.e. those who no longer met the criteria for inclusion
in the study at the end of the trial, as per their protocol) in the
low-allergen group (35 of 47 intervention responders) compared
with the control group (16 of 43 control responders). The low-
allergen diet excluded all dairy products, soy, wheat, eggs, peanuts,
tree nuts and fish, and included a ricemilk drink, meat, vegetables,
fruit, corn and rice, as well as a calcium supplement and rice-based
bread. We rated the quality of this evidence as very low due to
risk of bias and imprecision (Summary of findings for the main
comparison).
Neither study assessed our other secondary outcomes: frequency
of crying episodes per 24 h, parental or family quality of life, infant
sleep duration per 24 h, parental satisfaction or adverse effects.
2. Low-allergen diet or soy milk formula versus the
addition of dicyclomine hydrochloride
Only one study (120 infants) contributed data to this compar-
ison (Oggero 1994). It compared a restricted, low-allergen diet
in breastfeeding mothers or soy milk in formula-fed babies ver-
sus the addition of dicyclomine hydrochloride (a pharmacological
treatment for stomach spasms) for both breastfed and formula-fed
infants in the treatment group, over a period of 30 days.
Primary outcome: duration of crying
Authors did not specifically report duration of crying at end of
intervention.
Secondary outcomes: number of responders in each group
after treatment
Oggero 1994 reported data on this outcome, but investigators
used stricter rules for classifying ’improvement’ compared to our
protocol (Savino 2014), stating “A positive result was defined as a
reduction of crying to less than one hour per day after 48 hours of
treatment, with remission persisting for one month”. The study
found that 10/15 (66.6%) breastfed babies responded to dicy-
clomine hydrochloride, compared with 24/45 (53.36%) formula-
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fed babies. There was little difference in response between breast-
fed babies whose mother changed their diet (10/16; 62.5%) and
babies who received soy milk formula (29/44; 65.9%).
The study did not assess our other secondary outcomes: frequency
of crying episodes per 24 h, parental or family quality of life, infant
sleep duration per 24 h, parental satisfaction or adverse effects.
3. Hydrolysed formula versus standard formula
Three studies involving 185 infants compared an extensively hy-
drolysed cows’ milk formula with standard cows’ milk formula
(Forsyth 1989;Hill 1995; Lucassen 2000). One study did not sep-
arate the results for breastfed and formula-fed infants (Hill 1995),
and the study author provided no further details in response to
our request, so we could not include the data in a meta-analysis.
Primary outcome: duration of crying
Two studies (64 infants) reported dichotomous data on this out-
come (Forsyth 1989; Lucassen 2000). They found no difference
between the hydrolysed formula versus the standard formula us-
ing a random-effects model (RR 2.03, 95% CI 0.81 to 5.10; Tau
2 = 0.13, Chi2 = 1.40, df = 1 (P = 0.24), I2 = 28%; Analysis 1.1;
Figure 4).We conducted a sensitivity analysis using the fixed-effect
model and found no difference in the result (RR 2.02, 95% CI
0.96 to 4.26; Chi2 = 1.40, df = 1 (P = 0.24), I2 = 28%; Analysis
1.2; Figure 5). We rated the quality of this evidence as very low
(Summary of findings for the main comparison).
Figure 4. Forest plot of comparison: 1 Extensively hydrolysed versus standard formula, outcome: 1.1
Resolution of colic. Random-effects model
Figure 5. Forest plot of comparison: 1 Extensively hydrolysed versus standard formula, outcome: 1.2
Resolution of colic. Sensitivity analysis using a fixed-effect model.
Only one study (43 participants) reported continuous data on this
outcome (Lucassen 2000), demonstrating a greater reduction in
crying time postintervention with the hydrolysed formula (104
min/d, 95% CI 55 to 155) than with the standard formula (3
min/d, 95% CI −63 to 67). We rated the quality of the evidence
as very low (Summary of findings for the main comparison).
Secondary outcomes: adverse effects
Lucassen 2000 did not report on adverse effects, but we received
further information from the study author indicating that there
were no adverse effects. The other two studies did not report on
adverse effects either, so it was not possible to conduct an analysis
of any adverse effects or causes of dropouts from the studies from
use of the hydrolysed formulas (Forsyth 1989; Hill 1995). We
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rated the quality of the evidence as very low (Summary of findings
for the main comparison).
None of the three studies assessed our other secondary outcomes:
number of responders in each group after treatment, frequency of
crying episodes per 24 h, parental or family quality of life, infant
sleep duration per 24 h or parental satisfaction.
4. Hydrolysed formula versus hydrolysed formula
One study (22 infants) was designed as a cross-over trial, with each
infant receiving both types of formula for aweek (Jakobsson 2000).
In this study, 10 infants were randomised to receive Alimentum
(manufactured by Abbott) and 12 infants to receive Nutramigen
(manufactured by Mead Johnson).
Primary outcome: duration of crying
The study authors concluded that both hydrolysed formulas were
equally effective in resolving symptoms for babies in the trial who
were on standard formula to begin with: Alimentum reduced cry-
ing to 2.21 h/d (SD 0.40) and Nutramigen to 2.93 h/d (SD 0.70).
Only one of the 22 babies did not have resolution of symptoms on
either hydrolysed trial formula at study end. We rated the quality
of this evidence as very low (Summary of findings for the main
comparison).
Secondary outcomes
The study did not assess any of our secondary outcomes: number
of responders in each group after treatment, frequency of crying
episodes per 24 h, parental or family quality of life, infant sleep
duration per 24 h, parental satisfaction or adverse effects.
5. Hydrolysed formula or dairy- and soy-free maternal
diet versus parental education or counselling
One study (21 participants) reported data on this comparison
(Taubman 1988).
Primary outcome: duration of crying
Taubman 1988 found that the crying of babies per 24 h in the
hydrolysed or dairy- and soy-free group decreased to 2.03 h (SD
1.03) by nine days into the intervention (P = 0.01). In the parent
education or counselling group, the crying of babies per 24 h
decreased to 1.08 h (SD 0.7) after nine days (P = 0.001). We rated
the quality of this evidence as very low (Summary of findings for
the main comparison).
Secondary outcomes
The study did not assess any other of our secondary outcomes:
number of responders in each group after treatment, frequency
of crying episodes per 24 hours, parental or family quality of life,
infant sleep duration per 24 h, parental satisfaction or adverse
effects.
6. Partially hydrolysed, lower lactose, whey-based
formula containing oligosaccharide versus standard
formula with simethicone
One study (267 infants) analysed the effectiveness of a par-
tially hydrolysed, whey-based formula containing a mixture of
oligosacharides, low lactose level,modified vegetable oil and starch
versus a standard formula (as used by parents) with simethicone
for infantile colic (Savino 2006).
Primary outcome: duration of crying time
Savino 2006 did not report data on this outcome.
Secondary outcomes
Frequency of crying episodes per 24 h
Savino 2006 found that infants receiving the partially hydrolysed
formula had a significant decrease (P <0.001) in colic episodes after
one week (2.47 episodes (SD 1.94) at day 7 versus 5.99 episodes
(SD 1.84) at study entry) compared with infants receiving the
standard formula (3.72 episodes (SD 1.98) at day 7 versus 5.41
episodes (SD 1.88) at study entry). After two weeks, episodes of
crying were significantly different (P < 0.001) between the two
groups of infants (partially hydrolysed formula: 1.76 episodes (SD
1.60) versus standard formula: 3.32 episodes (SD 2.06)). We rated
the quality of the evidence as very low (Summary of findings for
the main comparison).
Adverse effects
Savino 2006 did not report data on adverse effects, but the lead
author confirmed that these were assessed and recorded as part of
the protocol, and that no infants experienced them.
The study did not report data on any of our other secondary
outcomes: number of responders in each group after treatment,
parental or family quality of life, infant sleep duration per 24 h or
parental satisfaction.
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7. Lactase enzyme supplementation versus placebo
Three studies (138participants) investigated the addition of lactase
enzyme to infant milk (Kanabar 2001; Kearney 1998; Miller
1990). Once again, due to significant heterogeneity of outcome
reporting and limited data within the reports, as well as all three
studies being cross-over trials that did not report data from before
washout, we were unable to conduct a meta-analysis.
Primary outcome: duration of crying time
None of the three studies reported data on this outcome (Kanabar
2001; Kearney 1998; Miller 1990).
Secondary outcomes: adverse effects
Two studies reported that there were no adverse effects (Kanabar
2001; Kearney 1998), while the author of Miller 1990 confirmed
via personal correspondence that this was the case.
The study did not report on our other secondary outcomes: num-
ber of responders in each group after treatment, frequency of cry-
ing episodes per 24 h, parental or family quality of life, infant sleep
duration per 24 h or parental satisfaction.
8. Extract of Foeniculum vulgare, Matricariae
recutita, and Melissa officinalis versus placebo
One study with 93 infants, Savino 2005, assessed the effectiveness
and side effects of a phytotherapeutic agent versus placebo, both
of which were administered twice a day for one week, in the treat-
ment of infantile colic. The phytotherapeutic agent was a liquid
containing extract of Foeniculum vulgare (fennel), Matricariae re-
cutita (camomile) and Melissa officinalis (lemon balm), with vita-
mins B1, B5 and B6.
Primary outcome: duration of crying
Savino 2005 found that the average daily crying time of infants
given the phytotherapeutic agent was 76.9 min/d at the end of the
1-week study (SD 23.5), compared with an average daily crying
time of 169.9 min/d (SD 23.1) in infants given placebo (P < 0.01).
We rated the quality of the evidence as very low (Summary of
findings for the main comparison).
Secondary outcomes: adverse effects
Savino 2005 reported that there were no adverse effects. We rated
the quality of this evidence as very low (Summary of findings for
the main comparison).
Savino 2005 did not assess any of our other secondary outcomes:
number of responders in each group after treatment, frequency of
crying episodes per 24 h, parental or family quality of life, infant
sleep duration per 24 h or parental satisfaction.
9. Soy protein-based formula versus standard cows’
milk protein-based formula
Two studies (84 infants) compared a soy protein-based formula
with standard cows’ milk protein-based formula (Campbell 1989;
Lothe 1987). We were unable to conduct a meta-analysis as the
outcomes were extremely heterogeneous.
In the cross-over study (65 infants) by Lothe 1987, study authors
reported only aggregated results and did not respond to our re-
quest for data from the first arm only. Therefore, we are unable to
consider the results any further.
Campbell 1989 (19 infants) compared duration of symptoms of
colic following a single week on either a standard casein-based
cows’ milk protein formula (as control) or the same company’s
(Cow and Gate) soy formula. The study was run as a cross-over
with all babies receiving both formulas over the space of twoweeks.
However, for the purposes of this review and as per our protocol
(Savino 2014), we considered data from the first arm (first week)
only. See Unit of analysis issues.
Primary outcome: duration of crying
In Campbell 1989, mean crying time was lower in the soy protein-
based formula group (12.7 h/week (SD16.4)) than in the standard
cows’ milk protein-based formula group (17.3 h/week (SD 6.9)).
We rated the quality of the evidence as very low (Summary of
findings for the main comparison).
Secondary outcomes: number of responders in each group
after treatment
Campbell 1989 reported 0/9 responders (0%) in the control group
and 5/10 responders (50%) in the intervention group. We rated
the quality of the evidence as very low (Summary of findings for
the main comparison).
The study did not assess our other secondary outcomes: frequency
of crying episodes per 24 h, parental or family quality of life, infant
sleep duration per 24 h, parental satisfaction or adverse effects.
10. Soy protein formula with polysaccharide versus
standard soy protein formula
One study (27 infants) assessed this comparison (Treem 1991).
Twelve babies received standard soy protein formula, and 15 babies
received a formula supplemented with polysaccharide. As we did
not receive a response from the study author to our request for
pre-washout-phase data, we are unable to analyse these results.
Primary outcomes: duration of crying
Treem 1991 did not report data on this outcome.
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Secondary outcomes
Treem 1991 did not present pre-washout-phase data to allow us
to assess our secondary outcomes: number of responders in each
group after treatment, frequency of crying episodes per 24 h,
parental or family quality of life, infant sleep duration per 24 h,
parental satisfaction or adverse effects.
D I S C U S S I O N
Summary of main results
This review includes 15 studies, with a total of 1121 enrolled in-
fants, that evaluated the effects of dietarymodifications for treating
infant colic. We were able to perform only one meta-analysis, for
the comparison ’extensively hydrolysed versus standard formula’,
and we found no difference between the groups.
The studies did not routinely report adverse effects, although a
small number of study authors provided these data on request.
Despite some study authors concluding that dietary modifications
are effective, our meta-analysis found no evidence in favour of any
of the interventions proposed on duration of crying, despite this
being the key outcome of interest to professionals and parents.
There were also no studies reporting data on quality of life out-
comes, which are of great interest to parents.
There is insufficient evidence to support the claims that soy protein
benefits infants with fussiness and crying, in keeping with inter-
national guidelines (ESPGHAN) (Agostoni 2006), and that sug-
gested soy milk formulas should not be used (see section Quality
of the evidence below).
In sum, dietary modifications may or may not be useful or detri-
mental.
Overall completeness and applicability of
evidence
The results of this review rest upon trials which, in general, were
poorly designed, conducted and reported. Even though the studies
were conducted in both university clinics and primary care hos-
pitals in different countries, the applicability of the evidence to
clinical practice is limited. Most dietary modifications explored by
the trials, such as soy-based formula, were outdated, and clinical
outcomes and data, such as adverse effects, were limited. More-
over, heterogeneity was evident among definitions of colic. Studies
were most often based on a small sample from a single centre, with
no replication.
The number of infants included in the comparisons was low, rang-
ing from 13 for lactase drops versus placebo, to 267 for partially
hydrolysed, low-lactose, modified-oil, whey-based formula con-
taining oligosaccharide and starch versus a standard formula with
simethicone.
The small sample sizes do not reflect the large scale of the issue
with infantile colic in our populations. In over 30 years of research
included in this review, the studies we found are not robust enough
to provide definitive answers regarding which - if any - dietary
modification works. Nor do they shed any light on what colic
is, a clearly symbiotically linked problem that also requires study.
Most research apparently concentrates on testing specific products
rather than the individual ingredients and their efficacy.
The outcome measures used are also of concern. As crying is a
very subjective concept, objective methods of recording crying
would be preferable. However, recording in diaries was the most
common method, and this is a significant weakness in the utility
of the evidence base. The use of ’treatment success’ or ’responders’
was also reported in a very heterogenous manner, and many of the
specific thresholds reported bear little utility to parents or clinicians
in real-life clinical situations.
Unfortunately, the included studies did not evaluate the impact of
interventions on the quality of family life with the colicky infant.
Validated questionnaires are available for parents (Sung 2014),
and, in many ways, this is the most important set of measures for
a self-limiting problem that does not necessarily require treatment
but is treated to enhance outcomes for families. However, to date,
investigators have failed to recognise the impact that symptoms
of colic can have on parents’ emotional state (Landgren 2010).
This is a very sensitive issue because this clinical situation could
damage the future parent-child relationship (Pauli-Pott 2000). In
a recent systematic review of outcome measures reported in trials
of infant colic, Steutel 2014 suggested a core set of measures that
would address such issues. As the natural history of the condition
is improvement, outcomes that measure the impact of symptoms
whilst present are, in many ways, the most relevant, and the lack
of reporting limits the applicability of the evidence.
In 2004 the UK’s Chief Medical Officer, Sir Liam Donaldson,
stated that soy-based formulas should be avoided for infants be-
cause of the “high phytoestrogen content, which could pose a
risk to the long-term reproductive health of infants” (Donaldson
2004). This recommendation was based on “a 2003 report from
the Committee on Toxicity (COT), an independent scientific
committee that advises the Department of Health and other gov-
ernment agencies”. It is unlikely, therefore, that studies would now
consider soy formula at all and instead would go straight to exten-
sively hydrolysed formula as the dietary modification for breastfed
babies (see Forsyth 1989;Hill 1995 and Lucassen 2000 above, and
to some extent Taubman 1988 also). This limits the applicability
of these earlier studies to current practice.
Quality of the evidence
We judged the quality of the evidence on the effectiveness of di-
etary modifications for infantile colic to be very low. This was
particularly impacted by the high risk of bias in the design and
conduct of studies, and a particular concern of publication bias
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linked to small study sizes, possibly associated with nutrition com-
pany sponsorship. Additionally, sample sizes were universally very
small, with no power calculations, further downgrading quality
for imprecision.
The lack of signalled adverse effects in the studies raises serious
doubts about the quality, accountability and transparency of these
trials. In any medical research, a researcher’s first priority is to be
accountable for exploring the effectiveness of different interven-
tions while protecting the safety of patients. It is obviously prefer-
able for researchers to contribute to improvements in the safety of
healthcare interventions by recording all potential adverse effects.
Collecting data on adverse effects in small children might require
additional efforts, as researchers would often need to train care-
givers to recognise and record potential adverse effects.
Given what has been said above, and the consequent low quality
of the evidence, readers should exercise caution when interpreting
the available data. Even if some results look positive (e.g. for hy-
drolysed protein formulas), it is possible that the advantages men-
tioned could simply be due to bias or chance. Based on the evi-
dence presented, we cannot recommend hydrolysed protein for-
mulas or other dietary modifications, and an allergen exclusion
diet is no better than standard diet or placebo.
Potential biases in the review process
We conducted comprehensive searches, including extensive
searches of the grey literature, to identify all relevant studies.
To avoid bias, two review authors (MG; SB) independently evalu-
ated study eligibility, extracted data, assessed risk of bias and rated
the quality of the evidence. On two occasions we resolved initial
disagreements about inclusion or exclusion with another member
of the team (FS). For the three studies in which one review author
(FS) was involved (Oggero 1994; Savino 2006; Savino 2005), two
other review authors (MG; SB) who did not participate in these
studies evaluated study eligibility, extracted data, assessed risk of
bias and rated the quality of the evidence.
Agreements and disagreements with other
studies or reviews
We found three earlier reviews evaluating dietary modifications
for infantile colic (Cohen-Silver 2009; Hall 2012; Perry 2011).
Cohen-Silver 2009 concluded that physicians can suggest a change
to formulas containing whey hydrolysate for formula-fed infants,
as well as maternal dietary modifications for breastfed infants. In
our view, however, the conclusions appear to over-interpret the
results of primary studies, not taking into account the poor qual-
ity of the evidence. Although Cohen-Silver 2009 underlines that
exclusive hypoallergenic formula feeds should be reserved only for
infants with a true allergy to cows’ milk protein, change to hydrol-
ysed formulas cannot generally be advised to parents as routine
clinical practice.
Hall 2012 is a systematic review of studies of several nutritional
interventions such as high-fibre formula, low-allergenic formula,
lower allergenic maternal diet or the addition of lactase. Hall 2012
agreed with our review in that the quality of the research in this
field must be recognised as a priority across different independent
research groups.
Perry 2011 published a broad overview of all complementary and
alternative medicines and nutritional supplements for the treat-
ment of infantile colic. While we considered some of the trials in
Perry 2011, they did not focus on dietary approaches with infant
formulas or dietary modifications for breastfeeding mothers, so
their scope was very different from ours. Also, their team con-
cluded that there was no evidence to support clinical recommen-
dations of any studied dietary intervention.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We have concluded the following.
1. It is not possible to draw any robust conclusions on the
effectiveness of dietary modifications for infantile colic because
the evidence is scant and prone to bias; presently, only a few trials
are available, most of them outdated and at serious risk of bias.
2. Only one unreplicated study, with high risk of bias in
several areas, found that parental education or counselling
achieves a significant decrease in crying within the first three days
compared to a dairy-free maternal diet or extensively hydrolysed
formula.
3. It is not possible to draw any conclusions on the efficacy of
dairy-free diets, soy-free diets, lactase enzyme supplementation
of infant milk, or the addition of soy polysaccharide to standard
soy protein formula.
4. Amongst studies examining the effect of an allergen-
exclusion diet in breastfeeding mothers, we found a significant
difference between responders in the low-allergen group versus
the control group. However, because the quality of these studies
is very poor, and the extent of the benefit observed is variable,
readers should interpret these results with caution.
5. Available data show no difference between hydrolysed and
standard infant formulas for colic; however, one study in our
review stated that the two different hydrolysed protein formulas
studied are equally effective in resolving symptoms.
6. Moreover, two different studies reported a reduction in
symptoms of infantile colic with hydrolysed formulas in other
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comparisons: in the first study, a partially hydrolysed, low-
lactose, modified-oil, whey-based formula containing
oligosaccharide and starch showed a significant decrease in colic
episodes compared with standard formula with simethicone. In
the second study, hydrolysed formula relieved symptoms of colic
after soy-based formula.
7. Given these interventions are not classified as medicinal
products by regulatory bodies, there is a risk that an
interventional dietary approach can be marketed to the public
with a poor evidence base that would not occur for prescribed
medicinal products. Thus, it is important to generate high-
quality evidence to investigate such new milk formulas and, in
the meantime, ensure the results of this review are used to guide
current clinical practice and advice.
The implication for practice from this systematic review is that
dietary modifications can be neither recommended nor excluded
from therapies, given their unknownbenefit, and that new research
must address keymethodological issues, some of which are context
specific.
Implications for research
Current evidence on the effectiveness of dietary approaches for
infantile colic is based mainly on old studies, which are usually
affected by methodological limitations.
Future trials must align with clinically relevant outcomes about
which there is a consensus regarding measurement methods and
relevant time points. Reporting the resolution of colic, defined
using up-to-date criteria for diagnosis, should be mandatory. Re-
garding crying time, objective measures using the host of audio-
visual and other technologies that are cheaply available, should be
considered essential to allow such assessment.
Other outcomes of importance to parents, such as crying time per
day, parental quality of life and sleeping time should be reported,
together with the data needed for synthesis. Adverse effects must
be reported in a manner that recognises the different forms of such
events (i.e. serious, minor and those requiring withdrawal of ther-
apy). Given the natural history of the condition, a major challenge
is to design trials that intervene early in the development of colic.
Alternatively, subgroups will permit consideration of different pa-
tients based on age, for example, since a population pre-six weeks
of age is, in many ways, very different from one that is post-six
weeks of age.
More rudimentary methodological issues must also be addressed.
Power calculations based on existing primary and secondary stud-
ies should be completed, as many of the studies we found were
underpowered and of little value. Long-term outcomes should be
considered, as this may allow economic evaluation in the future,
given that many of the interventions being studied in this review
are likely to be purchased directly by parents, and failure to address
colic can lead to extra visits with medical staff or requirement for
future medication.
Standardised tools for measuring outcomes that allow comparison
and pooling of results across studies are needed for all outcomes,
particularly given the new Rome IV criteria that refer to several
elements in defining colic that are too subjective on their own to
enable performance of sensible experimental studies (Drossman
2016). We would advise all future researchers to read this review
in detail to identify primary works that may support study design.
A recent published analysis of the existing tools being employed
underlines the need to design and validate new assessment devices
or scales for this clinical condition (GarcíaMarqués 2017), and this
analysis should consider this existing evidence base in its entirety.
As indicated above, in planning new clinical trials, researchers
should adopt a standard definition of infantile colic, such as the
definition proposed by the Rome IV Committee (Benninga 2016;
Drossman 2016; Wolke 2017), which includes the following di-
agnostic criteria for infantile colic: all of the following in infants
from birth to four months of age: paroxysms of irritability, fussing
or crying that start and stop without obvious cause; episodes last-
ing three or more hours per day and occurring at least three days
per week for at least one week; and no failure to thrive.
Given the growing evidence around the impact of infants’ balance
of gut microbiota on colic and other symptoms (Dubois 2016;
Savino 2017), clear sample populations should include birth cir-
cumstances (i.e. vaginal versus caesarean), and feedingmethod (i.e.
exclusive breastfeeding frombirth versus exclusive formula feeding
frombirth). In addition, the populations for future trials should be
separated, perhaps, into infants with a pre-existing family history
of allergy to a certain dietary component (e.g. soy or cows’ milk
protein) versus those who do not.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Campbell 1989
Methods Single-centre, double-blind, randomised controlled trial with 2 treatment groups
Participants Sample size: 19 infants diagnosed with colic (0 dropped out)
Setting: recruited in a single town (Livingston, West Lothian in Scotland, UK)
Sex: 11 boys (58%), 8 girls (42%)
Mean age: 7 weeks (SD not reported, range 3 to 14)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: formula fed (100%)
Birth order: 4 first born, 7 second born, 8 third to sixth born
Inclusion criteria: formula-fed infants with a clinical diagnosis were included in the
study if they met the Wessel 1954 criteria
Exclusion criteria: spontaneous remission in the observation week, colic not severe or
already improving during baseline week. Does not specify that babies were ’otherwise
well’; however, referral was via GP or HV who considered the baby to have infant colic
Interventions Intervention (n = 10): soy formula
Control (n = 9): standard formula
Duration: 1 week
Outcomes Mothers asked to complete a record sheet noting the amount of time of baby’s colic
symptoms each day. Record sheets scored by totaling all the periods of colic, to the
nearest half hour, for 6 days of the week, omitting the first day of the week to allow for
transition from previous milk
Notes Study start and end dates: not recorded; however it was a 2-year study period and
published in 1989
COIs: none stated
Funding source: formula provided by Cow & Gate. Author was a GP, doing a research
fellowship funded by the Health Service Research Committee of Scottish Home and
Health Department
Adverse effects: not reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “on the basis of random assign-
ment”
Comment: no further details given. Wrote
to study author but received no response
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Campbell 1989 (Continued)
Allocation concealment (selection bias) High risk Comment: nodetails given.Wrote to study
author but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “control and intervention were
packaged in identical coded tins”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “and the code of each pair of milks
was not broken until the end of the ... pe-
riod so that the observations would be dou-
ble blind”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all data recorded. Accounted
for all patients
Selective reporting (reporting bias) High risk Comment: no specific mention or report-
ing of adverse effects
Other bias Low risk Comment: not apparent
Forsyth 1989
Methods Double-blind, randomised control trial with 2 treatment groups (cross-over study but
we are using just the first trial)
Participants Sample size: 32 infants (40 referred but 8 did not satisfy eligibility criteria) diagnosed
with colic enrolled (15 dropped out: 6 did not begin taking the formula, 5 did not
complete the diary and 4 discontinued the study after beginning it - specific groups not
described)
Setting: private practitioners andDepartment of Pediatrics, and Yale Child StudyCenter,
New Haven, Connecticut, USA
Sex: 11 boys (65%)
Mean age: 5.38 weeks (SD 1.54, range 4 to 7)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: formula fed (100%)
Birth order: not reported
Inclusion criteria: aged 8 weeks or less at the time of enrolment, formula fed, crying
reported 3 or more h/d, parents’ subjective description of colic
Exclusion criteria: any other causes of excessive crying
Interventions Intervention (n = 9): Nutramigen casein hydrolysate
Control (n = 8): ”a cow milk formula” (quote); 1 part Enfamil (standard formula) and
2 parts Nutramigen, to ensure blinding or alternative as per cross-over trial
Duration: 4-day period and then crossed over
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Forsyth 1989 (Continued)
Outcomes Mothers recorded crying episodes in diaries and indicatedwhich episodes they considered
to have been caused by colic. Crying quantified in h/d
Notes Study start and end dates: not reported, although this paper was written in early 1989
COIs: none specifically reported; however, study funded bymanufacturers of the product
that was used as the intervention
Funding source: supported by a grant from Mead Johnson, whose products were used
Adverse effects: not reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “random assignment table of ran-
dom numbers”
Allocation concealment (selection bias) Low risk Comment: assignment by central phar-
macy
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Comment: described as double-blind, but
no details given and none received from
study author
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: described as double-blind, but
no details given and none received from
study author
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: only partial details given on
dropouts and which group they were from.
Whilst some inference can be made for an
intention-to-treat analysis, further details
were not available from the study author
Selective reporting (reporting bias) High risk Comment: no specific mention or report-
ing of adverse effects. No response received
from study author
Other bias High risk Comment: report says that cans of formula
were prepared by Mead Johnson. No fur-
ther details of involvement and no response
received from study author
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Hill 1995
Methods Double-blind, randomised, placebo-controlled trial over 1 week with 4 treatment groups
Participants Sample size: 38 formula-fed and 77 breastfed infants (36 dropped out - 18 in each
group)
Setting: metropolitan, community-based, well-infant centres, Melbourne, Australia
Sex: not reported
Mean age: not reported (SD not reported, range 7.0 to 7.9 weeks)
Mean weight: not reported
Mean duration of colic (baseline): 5.1 h/d (SD 3.0) intervention, 5.9 h/d (SD 3.1)
control
Mean crying (baseline): not reported
Feeding: formula fed (33%; n = 38)
Inclusion criteria: aged 4-16 weeks, uncomplicated pregnancy of more than 37 weeks’
duration, uneventful perinatal period, colic definition ’rule of three’, and otherwise
healthy except for colic. Also included those on medication for colic, as long as medica-
tions continued throughout the trial
Exclusion criteria: not reported
Interventions Intervention (n = 54): mothers of breastfed babies given a hypoallergenic or anti-
oligogenic diet (excluding food dyes, additives, preservatives, milk, egg, wheat or nuts),
and formula-fed babies provided with a casein based hydrolysate formula (Pregestamil)
Control (n = 61): mothers of breastfed babies given a standard oligoantigenic diet
(avoiding food dyes, additives, preservatives), and formula-fed babies given standard
formula (Enfamil Reduced Iron)
Duration: 1 week
Outcomes Parents instructed in the use of a 24-h distress score chart, which they were asked to
complete on day 1 and day 8 of the trial, with distress marked in min/h
Notes Study start and end dates: not reported; however, paper does report that the original
study was intended to be 12 months, but that it was harder to recruit than they had
expected and the study was finally closed after 3 years
COIs: none reported
Funding source: supported by a grant from Mead Johnson
Adverse effects: none reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: says it is randomised. Wrote to
study author but received no response
Allocation concealment (selection bias) Low risk Comment: sealed envelopes for assignment
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: double-blind - identical sealed
tins
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Hill 1995 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: as above
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all patient outcomes described
Selective reporting (reporting bias) High risk Comment: no specific mention or report-
ing of adverse effects. No response received
from study author
Other bias High risk Comment: supported by a grant from
Mead Johnson. No further details of in-
volvement and no response received from
study author
Hill 2005
Methods Randomised controlled trial with 2 treatment groups
Participants Sample size: 107 infants (17 dropped out - intervention = 6, control = 11)
Setting: metropolitan, community-based, well-infant centres, Melbourne, Australia
Sex: 54 boys (50%) 53 girls (50%)
Mean age: 5.7 weeks (SD 1.1, range 2.9 to 8.6)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: breastfed (100%)
Birth order: not reported
Inclusion criteria: < 6 weeks of age, breastfed, well-term infants (gestational age of >
37 weeks), normal singleton pregnancy, otherwise uneventful perinatal history and no
perinatal morbidity other than distress, and presence of ’rule of three’ crying in the week
before presentation
Exclusion criteria: mothers who were vegan, babies who were formula fed, spontaneous
improvement
Interventions Intervention (n = 47): low-allergen diet without milk, soy, nuts, eggs, wheat and soy,
but including a rice drink every day and rice bread
Control (n = 43): diet must have included milk, peanuts, egg, wheat, fish, tree nuts and
soy every day
Duration: 1 week
Outcomes Detailed food diary by mothers, and recording of infant crying or fussing behaviour on
a pre-validated chart, for 48 h on days 1, 2, 8 and 9
Notes Study start and end dates: 2000 (start) to 2002 (end)
COIs: not reported but see funding source directly below
Funding source: financed by the Rice Growers’ Co-operative, Australia. Intervention
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Hill 2005 (Continued)
was rice milk and rice bread
Adverse effects: none reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “referred to the Department of Al-
lergy for diet randomisation”
Quote: “assigned to one of the diets by the
research dietician on the basis of a randomi-
sation schedule provided by the statistician”
Comment: no further details. Wrote to
study author but received no response
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: not possible to blind partici-
pant mothers as diets were different
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Comment: not possible to blind partici-
pant mothers as diets were different
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: participant enrolment/study
progress diagram included in paper. Ac-
counted for all participants
Selective reporting (reporting bias) High risk Comment: no specific mention or report-
ing of adverse effects. No response received
from study author
Other bias High risk Comment: funded by Rice Grower’s Co-
operative, and intervention includes a rice
drink and rice bread daily. No further de-
tails of involvement and no response re-
ceived from study author
Jakobsson 2000
Methods Randomised, cross-over-style, baseline-control trial with 2 treatment groups
Participants Sample size: 22 enrolled infants (7 dropped out - 3 from CH1 and 4 from CH2)
Setting: outpatient clinic of a hospital. Recruited from well-baby clinics in Malmö,
Sweden
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Jakobsson 2000 (Continued)
Sex: 7 boys (47%) 8 girls (53%)
Mean age: not reported (SD not reported, range 2 to 8 weeks)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): 7.36 h/d (SD 1.32)
Feeding: formula fed (100%)
Birth order: not reported
Inclusion criteria: severe colic: “crying for many times per day for at least 4 days in a
week, and continuing for one week or more with each episode lasting 30 minutes to 2
hours, totaling > 3 hours per day” (quote). Symptoms not resolved after parenting and
feeding advice given to mother. Anti-spasmodic and anti-cholinergic drugs to manage
the colic may have been tried prior to enrolment
Exclusion criteria: spontaneous resolution, removed for vomiting, refused to follow the
protocol, families must not have previously used hydrolysed formula for their babies
Interventions Intervention (n = 22): Alimentum hydrolysate formula with iron (Abbott Laboratories,
CH1) or Nutramigen hydrolysate formula with iron (Mead Johnson Nutritionals, CH2)
Control (n = 22): baseline infant’s standard formula
Duration: 1 week
Outcomes Parents recorded daily crying time in h/d, crying intensity, and other colicky behaviour
(summarised as a percentage of the days a particular feature was observed). Formula
intake and stool consistency also recorded
Notes Study start and end dates: not reported
COIs: not reported
Funding source: not reported
Adverse effects: none reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “at enrolment, infants were ran-
domised to one of two feeding sequences:
CH1 for a week then CH2, or CH2 for a
week then CH1 in crossover style”
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but no received response
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Comment: no details. Wrote to study au-
thor but received no response
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Jakobsson 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: some data missing after death
of one of the investigators
Selective reporting (reporting bias) High risk Comment: no specific mention of adverse
effects
Other bias Low risk Comment: none noted
Kanabar 2001
Methods Double-blind, randomised, placebo-controlled cross-over trial with 2 treatment groups
Participants Sample size: 53 infants (7 dropped out - groups not clear)
Setting: Guy & St Thomas Hospital London, UK
Sex: not reported
Mean age: not reported (SD not reported, range 3 to 13 weeks). Mothers given trial
literature in the recovery room after birth and asked to get in touch if their babies had
colic
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: not reported
Birth order: not reported
Inclusion criteria: visit from community midwife at home to establish if baby meets
trial criteria. Colic according to Wessel criteria adapted to 14 days of symptoms, does
not specify that infants were otherwise well, but recruitment was via general population
and supervised by a midwife
Exclusion criteria: changes of address, and a failure to understand the dosage instructions
Interventions Intervention (n = not stated): Colief lactase drops. For formula-fed babies, 2 drops
added to every made-up formula bottle then bottle refrigerated for 4 h before use. For
breastfed babies, mother to express ’foremilk’ onto a spoon, add 4 drops of lactase, and
then give this at the end of a feed (having tested this method of short incubation with
small volume of milk in vitro, using 15 mL Aptamil - not breast milk)
Control (n = not stated): heat inactivated placebo of the lactase obtained from the
manufacturer, in identical packaging, delivered in the same way
Duration: treatment for each feed for 10 days
Outcomes Parents noted total daily crying time in minutes over 10 days, and breath hydrogen
testing done before and after a single feed on day 10 to assess whether treatment produced
45% less crying time
Notes Study start and end dates: not reported
COIs: Treatment products - both intervention and control - provided by Crosscare Ltd,
the manufacturer of Colief, which was being tested in this study
Funding source: not reported but see COIs directly above
Adverse effects: none reported
Comments: none
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Kanabar 2001 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomly assigned by use of a pre-
determined computer-generated randomi-
sation schedule, to verum or placebo arm
for 10 days”
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: double-blind, identical pack-
aging of intervention and control
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: says double-blind but paper
does not make clear whether outcome as-
sessors were aware of treatment arm when
analysing parents’ records. Wrote to study
author but received no response
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: paper states that 46 (out of 53)
participants were available for “cry time
analysis” (quote) and the reasons for non-
availability included changes of address and
failure to understanddosage instructions. A
significant proportion (14/46) were found
to be non-compliant with the usage of the
lactase or placebo (judged by the amount
that was gone from the bottle)
Selective reporting (reporting bias) Low risk Comment: paper reports on per-protocol
and intention-to-treat data but the results
from the two cross-over arms are lumped
together so meta-analysis not possible
Adverse event data given
Other bias High risk Comment: this is a cross-over study but the
data is lumped together so we could not, as
preferred, refer only to data from the first
arm of the study. Wrote to study author for
separate data but received no response
Treatment products - both intervention
and control - provided by Crosscare Ltd,
the manufacturer of Colief, which was be-
ing tested in this study
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Kearney 1998
Methods Randomised, double-blind, cross-over trial with 2 treatment groups
Participants Sample size: 13 infants (0 dropped out)
Setting: general practices and paediatric clinics in Cork, Ireland
Sex: 9 boys (69%) 4 girls (31%)
Mean age: 53.5 days (SD 26.2, range 23 to 113 days)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: formula fed (100%)
Birth order: not reported
Inclusion criteria: formula-fed infants with colic symptoms using a modified Wessel’s
criteria: full force crying for ≥ 3 h/d for ≥ 3 d/week. Their definition did not require
crying of 3 weeks or more
Exclusion criteria: ’otherwise well’ (quote)
Interventions Intervention (n = not reported): lactase (Lactaid) drops; 3 drops added to each feed,
which was then refrigerated for 24 h before feeding to the baby
Control (n = not reported): placebo supplied by manufacturer for lactase (Lactaid)
drops; 3 drops added to each feed, which was then refrigerated for 24 h before feeding
to the baby
Duration: 1 week
Outcomes Parents asked to keep a diary containing information about baby’s crying time, stool
habit and details of volumes, strength and type of formula
Notes Study start and end dates: not known
COIs: none reported
Funding source: Mediplan and Myplan, who make the lactase product Lactaid, which
was used as the intervention
Adverse effects: none reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “random permutated blocks of size
four to ensure that the numbers of babies
assigned to the two treatment orders were
fairly even”
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “preparations given in bottles
marked week 1 and week 2 to ensure the
double blind nature of the trial”
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: no details at all.Wrote to study
author but received no response
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “13 babies completed the trial”
Comment: does not say how many began
the trial
Selective reporting (reporting bias) Low risk Comment: results from each cross-over
arm are lumped together in the data reports
so meta-analysis not possible
Adverse event data given
Other bias High risk Comment: funded by industry and no re-
sponse received from study author to con-
firm level of involvement
Lothe 1987
Methods Double-blind, cross-over trial with 1 treatment group
Participants Sample size: 65 infants (5 dropped out)
Setting: children’s hospital in Malmö, Sweden
Sex: 23 boys (38%) 37 girls (62%)
Mean age: 6.38 weeks (SD 2.50, range 3 to 13)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: predominantly or totally formula-fed infants
Birth order: not reported
Inclusion criteria: severe colic (paroxysmal abdominal pain, severe crying for several
hours per day especially between 5 pm and 10 pm, abdomen distended by gas, and
the wish to suck often). Infants receiving dimeticonum, methylscopolaminum and di-
cycloverine-chloride with no effect were able to participate
Exclusion criteria: urinary infections
Interventions Intervention (n = not clear): one can of ProSobee (soy protein-based formula) for 1
week
Control (n = not clear): Enfamil (standard cows’ milk protein-based formula) for 1
week
Duration: observation period of 1 week followed by a week of either cows’ milk protein-
based formula or soy protein-based formula. The infants were then swapped onto the
other formula and the results of the 2 cross-over arms’ were pooled for reporting in the
paper
Outcomes Parents given standardised protocols and asked to record the length of the crying period
and any changes in stools and vomit
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Notes Study start and end dates: 1980 (start); end date not reported
COIs: not reported
Funding source: control and intervention products manufactured and provided free by
Mead Johnson
Adverse effects: not reported
Comments: formulas were provided and coded byMead Johnson; any babies still symp-
tomatic on soy formula were then given cows’ milk protein hydrolysate formula Nu-
tramigen, also provided by Mead Johnson
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: says double-blind cross-over.
Does not say randomised anywhere
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: says double-blind cross-over.
Cans were labelled by Mead Johnson
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “at the end of the test period ... the
protocols were evaluated and the code was
broken”
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 60 participants (out of 65 at
outset) completed the trial. No explanation
of the other 5
Selective reporting (reporting bias) High risk Comment: reported on a per-protocol
rather than an intention-to-treat basis, no
specific adverse event data given
Other bias Unclear risk Comment: cans were labelled by Mead
Johnson
Lucassen 2000
Methods Randomised, double-blind, parallel trial with 2 treatment groups
Participants Sample size: 38 infants (5 dropouts: 2 from illness, 2 from non-compliance, and 1
referred because of worsening symptoms - 3 intervention, 2 control)
Setting: infants recruited from community-based, well-child clinics in 6 regions of an
area of Holland with 7500 births annually, co-ordinated by the Academic Hospital of
Vrije University, Amsterdam, The Netherlands
Sex: 19 boys (50%)
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Mean age: 7.7 weeks (SD not reported, range 6.4 to 8.9) intervention; 8.3 weeks (SD
not reported, range 6.6 to 10.1) control
Mean weight: 4.5 kg (4.2 to 4.8) intervention; 4.9 kg (4.3 to 5.6) control
Mean duration of colic (baseline): 403 min/day (341 to 466) intervention; 328 min/
day (291 to 366) control
Mean crying (baseline): 299 min/day (251 to 347) intervention; 267 min/day (226 to
307) control
Feeding: fully formula fed or fed with mix of breast and formula, but the paper neither
specifies how many babies were also receiving breast milk, nor treated the receipt of
breast milk as a confounding factor
Birth order: not reported
Inclusion criteria: infants with good medical condition on examination by clinic doctor,
thriving, formula fed (at least 1 formula feed per day), good feeding technique, < 6
months old, crying > 3 h/d on at least 3 d/week
Exclusion criteria: history of anaphylaxis to cows’ milk, previous trial of hypoallergenic
feeding, refusal to give informed consent, communication problems, referred to paedia-
trician, no crying problem anymore, other illness, other advice from own doctor, refusal
to keep diary
Interventions Intervention (n = 23): Nutricia whey hydrolysate formula
Control (n = 20): Nutricia standard formula
Duration: 1-week study after baseline for one week
Outcomes Parents instructed on the use of a 24-h diary and questionnaire to assess minutes of
crying per 24 h, which included the question, “Do you know which formula your infant
has been using this week?” (quote) to test for adequate blinding. Evaluation of results
to include proportion of infants who, after the intervention, would no longer meet the
inclusion criteria
Notes Study start and end dates: August 1994 (start) to October 1996 (end)
COIs: Nutricia provided the formula
Funding source: Praeventie Fonds - the Dutch National Preventative Fund
Adverse effects: none reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: randomised to intervention or
control group by SPSS Inc, Chicago
Allocation concealment (selection bias) Low risk Comment: response from study author as
follows (quote), “a box containing the for-
mula was sent to each participating centre.
Each box contained 16 cans of formula of
which 8 contained hypo-allergenic formula
and 8 normal formula (of which taste and
smell were changed in the direction of hy-
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poallergenic formula). All cans were identi-
cal and contained a sticker with a number.
Each set of two cans had the same num-
ber (so it was impossible to provide one
can with hypoallergenic formula and one
can with control formula to the same in-
fant). The local centre distributed the cans,
two for each infant. The persons at the lo-
cal centre were completely unaware of the
codes. The codeswere generatedwith a ran-
dom numbers list”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: study author responded. Blind-
ing of parents was made possible by chang-
ing the taste and smell of the control for-
mula in the direction of taste and smell of
the hypoallergenic formula
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Comment: study author responded. Blind-
ing of the parents was made possible by
changing the taste and smell of the control
formula in the direction of taste and smell
of the hypoallergenic formula
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: accounted for all participants
Selective reporting (reporting bias) Low risk Comment: study author contacted and we
were informed that there were no adverse
effects
Other bias Unclear risk Comment: Nutricia provided the formula.
Contact from the study author tells us that
Nutricia did not play any role except in
the provision of the formulas; they were
not involved in writing or checking the
manuscript
Miller 1990
Methods Double-blind, cross-over trial with 2 treatment groups
Participants Sample size: 15 (0 dropped out)
Setting: infants recruited from a family care centre serving the northern suburbs of
Sydney, Australia
Sex: 5 boys (33%) 10 girls (67%)
Mean age: 6.5 weeks (SD 2.2, range 3 to 9)
Mean weight: not reported
Mean duration of colic (baseline): not reported
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Mean crying (baseline): not reported
Feeding: breastfed (100%)
Birth order: not reported
Inclusion criteria: total duration of crying and fussing of at least 3 h in 2 consecutive
24-h periods; crying and fussing behaviour not responding to mother-craft skills, and
no apparent cause for the crying and fussing
Exclusion criteria: hydrogen concentration in breath of over 20 ppm
Interventions Intervention (n = not reported): lactase (Lactaid) in glycerol, 6 drops into baby’s mouth
within 5 min of commencing feed
Control (n = not reported): glycerol with water and caramel, 6 drops into baby’s mouth
within 5 min of commencing feed
Duration: 7 days in each treatment arm
Outcomes Mothers instructed on how to complete a 24-h recording form detailing durations of
infant behaviours such as sleeping, being awake and content, crying, fussing and feeding,
to determine themeannumber ofminutes of crying or fussing in 24h. Also,measurement
of H2 concentrations in pre-and post-prandial breath tests, to determine the effect of
yeast lactase on the mean value of each infants’ breath hydrogen
Notes Study start and end dates: July 1987 (start) to June 1988 (end)
COIs: none reported
Funding source: Sharpe Laboratories, which seemed to have produced the active and
placebo preparations, but no details available as to any further extent of their involvement
Adverse effects: none reported
Comments: cross-over study but we reported on the first arm only. Based on PhDThesis
by John Miller
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “infants were randomly allocated”
Comment: we contacted the study author
who was unable to confirm how the ran-
dom list was generated
Quote: “Dr D Shaw, Principal Consultant,
Siromath, Sydney, performed the sample
size calculation and I recall that he also pro-
vided a randomisation schema for alloca-
tion of the treatments to the breast fed, and
to the formula-fed infants. I don’t remem-
ber how these randomisation schema were
derived”
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor who was unable to confirm whether
this was done
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Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: described as double-blind but
method not specified. Wrote to study au-
thor who responded stating, “The active
& placebo enzyme preparations were asep-
tically filled into plastic squeeze bottles,
capped, packed into tamper-proof plain
cardboard cartons and labelled with a code
by Sharpe Laboratories, Sydney. The pack-
aged preparations were indistinguishable
except for the labelled code.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Comment: no details. Wrote to study au-
thor who responded stating, “The active
& placebo enzyme preparations were asep-
tically filled into plastic squeeze bottles,
capped, packed into tamper-proof plain
cardboard cartons and labelled with a code
by Sharpe Laboratories, Sydney. The pack-
aged preparations were indistinguishable
except for the labelled code.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 15 entered the study, but only
12 completed the study and no reasons for
non-completion are provided in the paper.
We contacted the study author who replied
stating, “Of these infants, 2 ‘dropped out’ -
1 on active treatment, the other on placebo.
In the former case, active treatment was
discontinued after 48 hours because the
parents considered the treatment worsened
crying and fussing behaviour. In the lat-
ter case, the mother stopped using the
placebo after 4 days because of lack of ef-
fect. One infant was withdrawn from the
study. In this case, themother was admitted
to hospital with a breast abscess. The in-
fant was temporarily weaned. However, at
the mother’s request, active treatment was
continued.”
Selective reporting (reporting bias) Low risk Comment: results are based on per pro-
tocol, not intention-to-treat, but all major
outcomes are reported, with adverse event
data given by study author
Other bias Unclear risk Comment: designed as cross-over trial but
we reported on the first arm only. Sharpe
Laboratories were the study sponsor and
seemed to have produced the active and
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placebo preparations but no details were
available as to any further extent of their
involvement. The study author confirmed
no involvement
Oggero 1994
Methods Randomised controlled trial with 3 treatment groups
Participants Sample size: 120 infants (0 dropped out)
Setting: Department of Pediatrics at the University of Turin, Children Hospital Regina
Margherita, Turin, Italy
Sex: not reported
Mean age: 6.2 weeks (SD not reported, range 3-12 weeks)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: formula fed (n = 89), and breastfed (n = 31). No mention of any of the babies
being mixed fed
Birth order: not reported
Inclusion criteria: infants aged 3-12 weeks suffering from severe colic, symptoms lasting
for at least 2 weeks, presence of inconsolable crying, closed fists and meteorism, pres-
ence of sleep disorders, crying for more than a total of 3 h/d, no response to common
consolation procedures (pacifier, rocking, dull continuous background noise, hot water
bottle on abdomen)
Exclusion criteria: known organic causes of abdominal pain
Interventions Intervention (n = 60): hypoallergenic dietary regimen. Breastfed babies’ mothers were
given a diet containing no milk, eggs or fish; formula-fed babies were given soy milk
(If symptoms continued the symptomatic, formula-fed babies were moved onto Nu-
tramigen for 15 days - these data are not included in our analyses)
Control (n = 60): gastrointestinal antispastic drugs. All infants given dicyclomine hy-
drocholoride (3 mg/kg/day divided into 3 doses per day), and no dietary modifications
were made
Duration: 15 days
Outcomes Parents asked to note the beginning and end of unexplained crying spells and to note
the beginning and end of unexplained periods of fussiness or irritability. The evaluation
of treatment results based on this information gathered by parents and written in a diary
Notes Study start and end dates: not reported in the text. October 1991 (start) to January
1993 (end)
COIs: none reported
Funding source: none reported
Adverse effects: none reported
Comments: none
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomly divided”
Allocation concealment (selection bias) High risk Comment: participants were randomly as-
signed to the different groups but the type
of treatment was known (not blinded)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: not possible to blind
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Comment: not a blinded study
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: accounted for all participants
Selective reporting (reporting bias) High risk Comment: study authors reported results
for all outcomes declared in the Methods
section, except adverse effects which are not
reported
Other bias Low risk Comment: no significant differences be-
tween groups at baseline were reported
Savino 2005
Methods Randomised, double-blind, placebo-controlled trial with 2 treatment groups
Participants Sample size: 93 colicky infants (5 dropped out (2 = intervention, 3 = control); 2 did not
come to the second visit, 3 were excluded because of fever. Nobody withdrew because
of problems related to the trial and therefore the study population may be considered
homogeneous)
Setting: recruited from patients seen at theDepartment of Pediatrics, ReginaMargherita
Children’s Hospital, University of Turin, Italy
Mean age: 4.2 weeks (SD 1.4, range not reported) intervention; 4.4 weeks (SD 1.6,
range not reported) control
Sex: 41 (46.6%) boys (18 intervention, 23 control); 47 (53.4%) girls (23 intervention,
24 control)
Mean weight: 3420 g (SD 390) intervention; 3510 g (SD 330) control
Mean duration of colic: not reported
Mean crying: 201.2 min (SD 18.3) intervention; 198.7 min (SD 16.9) control
Feeding: not specified
Birth order: not specified
Inclusion criteria: colic according to Wessel criteria, breastfed, healthy infants with
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regular growth, 21 to 60 days old, born at term (gestational age 38 to 42 weeks), birth
weight between 2500 g and 4000 g, no clinical evidence of gastroenterological disease,
and Apgar (appearance, pulse, grimace, activity, respiration) score > 7 at 5 min after birth
Exclusion criteria: infants receiving any medication, such as antibiotics or probiotics,
which could affect abdominal symptoms
Interventions Intervention 1 (n = 41): phytotherapeutic agent (extracts of Foeniculum vulgare (fennel)
, Matricaria recutita (chamomile), and Melissa officinalis (lemon balm)). Each dose of
herbal agent consisted of 1 bottle, with tank cap, containing Foeniculum vulgare miller
var. dulce (164.29 mg), Matricaria recutita L. (177.69 mg), Melissa officinalis L. (96.89
mg), vitamin B1 (0.85 mg), calcium pantothenate (3.24 mg), vitamin B6 (1.20 mg)
, maltodextrin (dose not specified) and syloid 244 FP (dose not specified) (ColiMil,
Milte-Milan, Italy). At the administered dosage, the herbal agent provided Foeniculum
vulgaremiller var. dulce 65.71mg/kg/d,Matricaria recutita L. 71.10mg/kg/d, andMelissa
officinalis L. 38.75 mg/kg/d
Control (n = 47): placebo looking like the phytotherapeutic agent with regard to colour,
smell, taste and package, but containing only vitamins. Each dose of placebo consisted
of 1 identical bottle, with tank cap, containing water obtained by inverted osmosis,
fructose, pineapple flavour, citric acid and sorbate potassium.
Administration: both herbal agent and placebo were administered twice a day at 5 pm
and 8 pm, some minutes before feeding, at a dosage of 2 ml/kg/d. Infants had to take
treatment consecutively for 7 days
Duration: 21 days
Outcomes Parents wrote a daily, structured diary, recording (1) the start of crying time - when
the medication was administered, (2) the end of crying time, and (3) any side effects
(vomiting, sleepiness, restlessness, appetite, cutaneous reactions, constipation, diarrhoea)
they observed for the 7 days of therapy and until day 21 from enrolment. Before starting
treatment, parents were invited to record data on daily crying time for 3 days (days 0, 1,
and 2). At days 1 and 7, infants were seen in the department, and parents gave the diary
to researchers. At day 21, after baseline, mothers were asked to complete a questionnaire
about crying time during the observation period. To ensure that all parents noted crying
time in a uniform way, and to ensure that infants were given medication correctly, a
researcherwas always available by phone tohelp parents. Therapywas considered effective
if crying time was reduced by≥ 50% per day; responders were infants who showed such
a reduction in crying time
Notes Study start and end dates: March 2001 (start) to March 2003 (end)
COIs: none reported
Funding source: funded, in part, by Milte who provided the study products but had no
other role in the study; they were not involved in writing or checking the manuscript
Adverse effects: no adverse effects
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Comment: this was performed by com-
puter
Allocation concealment (selection bias) Low risk Comment: conducted by a statistician not
involved with the study
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: placebo looked like the phy-
totherapeutic agent with regard to colour,
smell, taste and packaging
Quote: “Neither doctors nor parents knew
whether the infants received treatment or
not”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Neither doctors nor parents knew
whether the infants received treatment or
not”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 5 infants (2 from the interven-
tion group and 3 from the placebo group)
dropped out: 2 did not come to the second
visit, and 3 were excluded because of fever.
Nobody withdrew because of problems re-
lated to the trial
Selective reporting (reporting bias) Low risk Comment: study authors reported results
for all outcomes declared in the Methods
section
Other bias Low risk Comment: no significant differences be-
tween groups at baseline were reported
Savino 2006
Methods Prospective, randomised controlled trial with 2 treatment groups
Participants Sample size: 267 recruited (68 withdrawn (34 intervention, 34 control); 45 (20 inter-
vention, 25 control) did not meet inclusion criteria by the time the study began, and 23
(14 intervention, 9 control) excluded during the study due to missing data)
Setting: 78 general paediatricians and the Department of Pediatrics based at the Uni-
versity of Turin, Children Hospital Regina Margherita, Turin, Italy
Sex: 50 (52.1%) boys intervention, 49 (47.6%) boys control; 47.9% girls intervention,
52.4% girls control
Mean age: 1.39 months (SD 0.84, range not reported) intervention; 1.29 months (SD
0.77, range not reported) control; less than 4 months at age of entry into study
Mean weight: not reported
Mean duration of colic (baseline): 5.99 colic episodes per day (SD 1.84) intervention,
5.41 colic episodes per day (SD 1.88) control
Mean crying (baseline): not reported
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Feeding: formula fed (100%)
Birth order: not reported
Inclusion criteria: infants aged less than 4 months, with infantile colic according to
Wessel definition, gestational age between 37 and 42 weeks, normal birth weight (> 2500
g), regular weight gain (more than 150 g/week) and normal physical examination
Exclusion criteria: neonatal problems, consumption of any kind of medication during
the week before the beginning of the study and during the study period
Interventions Intervention (n = 130): Numic oOmneo Comfort (100% whey protein, low lactose,
contains GOS/FOS)
Control (n = 137): Numico Nutrilon Standard 1 formula plus simethicone (rationale
being that simethicone* is as effective as placebo (Lucassen 1998), so used as placebo)
Duration: 2 weeks
*Simethicone is an anti-foaming agent designed to reduce the surface tension of bubbles
of gas trapped in liquid, so they group together and can be passed more easily. As such,
this is not a dietarymodification and its addition to the standard formulawas intended, in
this case, to assess the superiority of the intervention formula, which contained oligosac-
charides thought to improve the balance of the infant’s microbiota, over the common
recommendation to administer simethicone to infants with colicky symptoms, alongside
their regular milk. The oligosaccharide blend used in this study formula was reported
as being 90% galacto-oligosaccharide and 10% fructo-oligosaccharide (known as GOS/
FOS), and the formula also had a 100% whey base rather than standard formula’s 60:
40 whey:casein ratio, and a lower lactose level than standard formula (with additional
maltodextrin and starch to thicken the milk), in addition to the cows milk proteins
having been partially hydrolysed. This study was a larger scale comparison with 103
of the infants who completed the trial randomised to the control with standard casein-
based formula plus simethicone, and 96 randomised to the intervention of a partially
hydrolysed, lower lactose, whey-based formula with starches, and supplemented with
oligosaccharide
Outcomes Questionnaire given to parents to monitor symptoms, frequency and feeding volume.
On days 1, 7 and 14, infants examined by paediatricians. Feeding frequency and feed-
ing volume was decided by the family and not by the study protocol. The number of
significant colic episodes (over 40 min in duration) was recorded by parents daily. Study
measured number of colic episodes per day (multivariate analysis between intervention
or control pairs adjusted for variables)
Notes Study start and end dates: August 2002 (start) to January 2003 (end)
COIs: none reported
Funding source: Numico, Italy, who provided the intervention formula
Adverse effects: not reported, but we contacted the author, who is also an author on
this review, who confirmed these were recorded and none were experienced
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Comment: effective randomisation
Allocation concealment (selection bias) Low risk Comment: sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: not possible because of sime-
thicone
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Comment: blinding of outcome assess-
ment performed by statistician
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 68/267 excluded at the end of
the trial for non-adherence to intervention
or control, or because lost to follow-up -
see above under ’Participants’. Clarified by
study author
Selective reporting (reporting bias) Low risk Comment: accounted for all participants.
Study authors confirmed no adverse effects
experienced
Other bias Unclear risk Comment: study supported by funds from
Numico, Italy. They were not involved in
writing or checking the manuscript
Taubman 1988
Methods Randomised controlled trial with 2 treatment groups. For our purposes, we have labelled
’maternal dairy-free diet’ and ’parental counselling plus usual diet’, as ’intervention’ and
’control’ respectively
Participants Sample size: 11 (1 dropout) in group 1; 10 (0 dropouts) in group 2
Setting: private practice and the gastroenterology clinic at the Children’s Hospital of
Philadelphia, Pennsylvania, USA
Sex: not reported
Mean age: 5.4 weeks (SD 2.2, range not reported) intervention; 6.5 weeks (SD 1.8,
range not reported) control
Mean weight: not reported
Mean duration of colic (baseline): 3.75 weeks (SD 5.8) intervention; 4.85 weeks (SD
4.12) control
Mean crying (baseline): 3.21 h/d (SD 1.10) intervention; 3.19 h/d (SD 0.69) control
Feeding: not reported
Birth order: 3 first born in each group (30%)
Inclusion criteria: infants crying for more than 2 h/d, younger than 3 months of age,
normal growth and development, normal physical findings, no history of diarrhoea or
vomiting, and receiving enough milk
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Exclusion criteria: babies already receiving Nutramigen hydrolysed milk or breastfed
babies whose mothers are already eating dairy-free
Interventions Intervention* (n = 11): maternal dairy-free diet if baby breastfed, or Nutramigen hy-
drolysed casein formula if baby formula fed
Control (n = 10): parental counselling plus usual diet
Duration: 9 days duration in each treatment arm of study
*The intervention group went on to have counselling along with return to usual diet.
This is not included in our analysis as is the second treatment arm, and we only used
data from first treatment arm
Outcomes Parents kept a diary of the infants behaviour, in the prescribed manner, during both
phases of the study and returned them to the investigator every 2 or 3 days
Notes Study start and end dates: not reported
COIs: none reported, but see funding source directly below
Funding source: funded, in part, by Mead Johnson, who provided the intervention
formula
Adverse effects: not recorded
Comments:this was a 2-phased, randomised study with 11 infants in the counselling
group (group 1) and 10 in the ’dairy and soy free’ group (group 2), although the first
group lost 1 participant from the study in the first few days and did not include that
infant’s data in the results. 3 infants in the counselling group were breastfed and 4 infants
in the dairy and soy free group were breastfed. This study was designed to show the
effectiveness of counselling by using dietary changes as a comparison
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: effective randomisation. Inves-
tigator had no knowledge of the allocation
until after consent was given
Allocation concealment (selection bias) High risk Comment: no details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: not possible given the nature of
the trial
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Comment: no details. Wrote to study au-
thor but received no response
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: accounted for all participants,
though paper reports per protocol, not in-
tention-to-treat, results after one partici-
pant dropped out of the control group
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Selective reporting (reporting bias) High risk Comment: paper reports per protocol, not
intention-to-treat, results after one partici-
pant dropped out of the control group. Ad-
verse effects not reported
Other bias High risk Comment: funded, in part, byMead John-
son, who provided the intervention for-
mula
Treem 1991
Methods Double-blind, randomised, 2-period, cross-over trial with 2 treatment groups
Participants Sample size: 33 infants (6 dropped out - sequence group not clear)
Setting: paediatricians in the greater Hartford community, Connecticut, USA
Sex: 13 boys (48%) 14 girls (52%)
Mean age: 34 days (SD not reported, range 10 to 54)
Mean weight: not reported
Mean duration of colic (baseline): not reported
Mean crying (baseline): not reported
Feeding: formula fed (100%)
Birth order: 15 first born
Inclusion criteria: crying as if in pain, crying suddenly, crying continuously for more
than 15 min at a time, and difficult or impossible to console during these crying spells,
with colic defined as more than 3 h crying or fussing per day on at least 3 days out of
6 successive days, birth weight > 2500 g, normal gestational age, absence of neonatal
problems, normal weight gain (> 150 g/week), normal physical examination
Exclusion criteria: infants on medications during the first week before or during the
study
Interventions Intervention (n = 12): Isomil with soy polysaccharide added to increase dietary fibre
(mean values 14.1 g dietary fibre per litre)
Control (n = 15): Isomil with nothing added (mean values 3.1 g dietary fibre per litre)
Duration: baseline for 1 week before beginning study. Cross-over study, including 3-
day washout between 2 × 9-day-long arms of study. Patients seen 5 times during the
study: at the beginning of the baseline period, at each of the 2 × 9-day study periods, at
the end of the last 9-day period, and at the 30- to 35-day follow-up period. Parents also
contacted by telephone at least once during each of the 2 × 9-day study periods
Outcomes Daily behaviour, feeding, and stool diaries completed for 27 days. At the end of this
time, parents asked to indicate during which study period the symptoms of colic were
most alleviated and whether the infant’s symptoms were alleviated during one of the
study periods more than during any time before the study. We did not include these data
in our analysis as we were looking only at the first arm
Results for crying and fussing in min per 24 h, but aggregated cross-over data
58Dietary modifications for infantile colic (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Treem 1991 (Continued)
Notes Study start and end dates not reported
COIs: none reported
Funding source: supported by grants from Ross Laboratories
Adverse effects: not reported
Comments: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: randomised
Allocation concealment (selection bias) High risk Comment: no details. Wrote to study au-
thor but received no response
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: double-blind and disguised
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: no details. Wrote to study au-
thor but received no response
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: accounted for all participants
Selective reporting (reporting bias) High risk Comment: accounted for all participants,
adverse effects not reported
Other bias High risk Comment: supported by grants from Ross
Laboratories who make Isomil. No further
details of involvement were available from
the study author
COIs: conflicts of interest;GP: general practitioner;HV: health visitor; SD: standard deviation; SPSS: Statistical Package for the Social
Sciences.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arikan 2008 Appears to be randomised, but study authors state that in order to prevent discontinuation of breastfeeding, only
participants who were formula fed went into the group receiving hydrolysed formula, so, in fact, not random
Barr 1991 Not suffering with colic on entry to study
Bellaiche 2018 Not an RCT
Berseth 2009 No definition of colic: “parent-identified as very fussy or extremely fussy in the baseline tolerance evaluation”
(quote)
Buchanan 1998 Letter to Editor of BMJ
Campeotto 2011 Not suffering with colic on entry to study
Dupont 2010 Using probiotics to treat so not dietary modification
Evans 1981 Not an RCT - no control
Gerrard 1984 Narative review only
Giovannini 2014 Not suffering with colic on entry to study
Iacono 1991 Not an RCT - no control
Iacovou 2018 Recruited infants did not match infantile colic criteria reported in their own Methods
Imanieh 2004 Study looking for skin prick test as predictor of cows’ milk protein allergy in colicky infants
Infante 2011 Not colic by our definition: only 35% (7 out of 20) infants included in analysis cried for more than 3 h/d at
baseline
Jakobsson 1983 Not an RCT or quasi-RCT
Koonce 2011 Narrative review only
Laws 1991 Letter to Editor of Journal of Pediatrics
Liebman 1981 Not an RCT or quasi-RCT
Nocerino 2012 Conference abstract; not randomised
Pärtty 2015 Using probiotics to treat so not dietary modification
Rozé 2012 Not suffering with colic on entry to study
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(Continued)
Sargsyan 2006 Letter to Editor of European Journal of Pediatrics
Savilahti 1989 Not an RCT or quasi-RCT
Savino 2003 Not colic by our definition
Sherman 2015 Not suffering with colic on entry to study
Vandenplas 2017 Not suffering with colic on entry to study
Vivatvakin 2010 Not suffering with colic on entry to study
Xinias 2017 Not an RCT - consecutive entry
RCT: randomised controlled trial.
Characteristics of ongoing studies [ordered by study ID]
NCT01721850
Trial name or title Title: Evaluation of safety and efficacy of new infant formula in infantile colic (Coco)
Official title: Evaluation of the safety and efficacy of new infant formula and its effects on the gastrointestinal
tolerance (crying time) in infantile colic: a double-blind, randomised, controlled intervention study
Methods Double-blind, randomised-controlled intervention study
Participants Inclusion criteria
1. Healthy, term infants
2. Participants appropriate for gestational age, between 35 and 41 weeks
3. Participants between 15 and 60 days old
4. Participants with birth weight between 2500 g and 4200 g, and with regular weight gain (≥ 150 g/
week)
5. Diagnosis of infantile colic according to modified Wessel criteria (crying episodes lasting ≥ 3 h/d and
occurring ≥ 3 d/week for at least 1 week)
6. Participants exclusively formula-fed at study entrance
7. Day care of the child only by mother or father or both
8. Provide written informed consent in accordance with legal requirement
Exclusion criteria
1. Neonatal problems (respiratory distress, asphyxia, Hypoglycaemia, sepsis, necrotising entercolitis)
2. Clinical evidence of chronic illness or gastrointestinal disorders (gastroesophageal reflux, gastroenteritis)
3. Assumption of any kind of medication (except vitamin D, vitamin K and fluoride prophylaxis) during
the week before the beginning of the study and during the study period
4. Participants receiving formula for special medical purposes
5. Exclusively breastfed infants
6. Feeding of supplemental probiotics or prebiotics (or both) 2 weeks prior to inclusion
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NCT01721850 (Continued)
7. Allergic diseases (manifest atopic dermatitis, cows’ milk allergy)
8. Participation in any other clinical intervention
Interventions Parallel assignment with 3 arms:
1. control formula (standard formula)
2. intervention formula 1 (infant formula with hydrolysed protein (type I) and pre- and probiotics
3. intervention formula 2 (infant formula with hydrolysed protein (type II) and pre- and probiotics
Outcomes Primary outcome
1. Daily total crying time (time frame: 28 days); evaluation of the difference in the average reduction of
daily crying time after 28 days of intervention between the intervention and control groups
Secondary outcomes
1. Growth parameters (time frame: 90 days); determination of body weight, length, head circumference
2. Tolerance evaluated by stool characteristics, gastrointestinal disorders and side effects (time frame: 28
days); stool characteristics: frequency, consistency and colour; gastrointestinal disorders: regurgitation,
obstipation; side effects: vomiting, diarrhoea, skin reactions
3. Formula intake (time frame: 28 days); evaluation of average daily drinking amount and formula
acceptance
4. Intestinal microbiota (time frame: 0 to 28 days); evaluation of changes in the composition of the
intestinal microbiota (lactobacilli, bifidobacteria, coliforms) after intervention
Starting date December 2011
Contact information Name: Christina Hecht
Email: Christina.hecht@hipp.de
Telephone: 00498441757855
Notes Status: recruiting
Funding source: HiPP GmbH & Co. Vertrieb KG
NCT02813772
Trial name or title Title: Efficacy of a partially hydrolyzed formula, containing Lactobacillus reuteri, for infant colic
Official title: Efficacy of a partially hydrolyzed formula, containingLactobacillus reuteri, for infant colic: a
double blind, randomised-controlled trial
Methods Double-blind, randomised controlled trial
Participants Inclusion criteria
1. Full-term infants (≥ 37 weeks gestation at birth)
2. Exclusively formula-fed infants at time of enrolment
3. Infants suffering from infantile colic according to Rome III criteria
4. Age < 4 months of life
5. 5-min Apgar (appearance, pulse, grimace, activity, respiration) score ≥ 7
6. Birth weight ≥ 2500 g
Exclusion criteria
1. Consumption of formula containing probiotics, partially hydrolysed formula or with reduced lactose
content at time of enrolment
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NCT02813772 (Continued)
2. Major medical problem or acute illness, including gastroesophageal reflux, cows’ milk protein allergy
3. History of antibiotic treatment before or during the study
4. History of probiotic or L reuteri supplementation
5. History of any allergies to any of the ingredients in the probiotic L reuteri
6. Concurrent participation in another clinical trial
7. Birth weight < 2500 g
8. Failed to thrive
9. Breastfed infants
10. NAN infant formula (to avoid the formula switch effect)
Interventions Parallel assignment: a partially hydrolysed formula with reduced lactose content and L reuteri versus a standard
formula
Outcomes Primary outcome
1. Whether the administration of a partially hydrolysed formula with reduced lactose content and L
reuteri is beneficial in infantile colic in reducing the infant crying duration (time frame: 7, 14, 21, 28 days, 2
and 3 months); infant crying duration (min/d) at 7, 14, 21, 28 days, 2 and 3 months postintervention
Secondary outcomes
1. Whether the administration of a partially hydrolysed formula with reduced lactose content and L
reuteri is beneficial in infantile colic in reducing the infant crying duration (time frame: 28 days); percentage
of responders at 28 days postintervention. A response to the treatment will be defined as 50% of reduction
of infant crying.
2. Whether the administration of a partially hydrolysed formula with reduced lactose content and L
reuteri is beneficial in infantile colic in increasing infant sleep (time frame: 7, 14, 21, 28 days, 2 and 3
months); longer infant sleep duration at 7, 14, 21, 28 days, 2 and 3 months postintervention
3. The effect of a partially hydrolysed formula on quality of life of the enrolled patients (time frame: 3
months); reduction of mean scores of a standardised measure for children’s quality of life
4. The effect of a partially hydrolysed formula on quality of life of parents (time frame: 3 months);
reduction of mean scores of a standardised measure for parents’ quality of life
5. The effect of this infant formula enriched with L reuteri on faecal microbiome of colicky infants (time
frame: 2 months); changes in gut microbiome
6. Changes in stool frequency and consistency (time frame: 28 days); changes in stool frequency and
consistency
7. Parental perception of colic severity (visual analog scale, 0 to 10) (time frame: 28 days); parental
perception of colic severity (visual analog scale, 0 to 10)
8. Parental perception of sleep quality (visual analog scale, 0 to 10) (time frame: 28 days); parental
perception of sleep quality (visual analog scale, 0 to 10)
Starting date November 2015
Contact information Name: Annamaria Staiano
Email: staiano@unina.it
Telephone: none provided
Notes Status: recruiting
Funding source: Federico II University
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NCT03329222
Trial name or title Title: An infant formula trial on dietary management of infantile colic
Official title: A randomised, double-blind, controlled, multi-centre study to assess the efficacy of an infant
formula in the dietary management of infantile colic
Methods Double-blind, randomised controlled trial
Participants Inclusion criteria
1. Infants aged 21-56 days (both inclusive)
2. Gestation age 37-42 weeks
3. Normal birth weight for gestational age and gender
4. 5-min Apgar (appearance, pulse, grimace, activity, respiration) score >7
5. Diagnosed with infantile colic
6. Fully formula fed for at least 7 days before randomisation
7. Written informed consent from the parent or legal representative (or both)
Exclusion criteria
1. Any plausible cause of inconsolable crying as judged by the investigator
2. Presence of non-functional vomiting or failure to thrive
3. Presence of any congenital defects in the gastrointestinal system or other defects preventing oral
nutrition
4. Combination of congenital condition or previous or current illness/infection and (or) medication use
that could interfere with the main study outcomes
5. Known cows’ milk protein allergy, lactose intolerance or galactosaemia, including presence of any
allergic manifestations
6. Received any special formula (e.g. lactose free, hydrolysed protein)
7. Received any of the following products/medication within 7 days before randomisation: probiotics,
systemic antibiotics, prokinetics, proton pump inhibitors
8. Twins or triplets or other infant(s) < 6 months of age living in the same household
9. Incapability of the parent(s) to comply with the study protocol or investigator’s uncertainty about the
willingness or ability of the participant to comply with protocol requirements
10. Current participation in another clinical study involving investigational or marketed products
Interventions An infant formula that contains specific hydrolysed proteins with a fat-blend, prebiotic mixture, starch and
reduced lactose versus standard cows’ milk with prebiotic mixture
Outcomes Primary outcome
1. Daily inconsolable crying time using data recorded on participant’s diaries (time frame: 6 weeks); daily
inconsolable crying time over 6 weeks
Secondary outcome
1. Daily crying time using data recorded on participant’s diaries (time frame: 6 weeks); daily crying time
over 6 weeks of intervention
2. Daily fussing time using data recorded on participant’s diaries (time frame: 6 weeks); daily fussing time
over 6 weeks of intervention
3. Daily inconsolable fussing time using data recorded on participant’s diaries (time frame: 6 weeks); daily
inconsolable fussing time over 6 weeks of intervention
4. Daily stool frequency using data recorded on participant’s diaries (time frame: 6 weeks); daily stool
frequency over 6 weeks of intervention
5. Daily stool consistency using data recorded on participant’s diaries (time frame = 6 weeks); daily stool
consistency over 6 weeks of intervention
6. The frequency of participants’ gastrointestinal symptoms of digestion in the 7-day period prior to the
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NCT03329222 (Continued)
visit using the Infant Gastrointestinal Symptoms questionnaire (time frame: 6 weeks); gastrointestinal
symptoms using the Infant Gastrointestinal Symptoms Questionnaire during the 6-week intervention period
7. The intensity of participants’ gastrointestinal symptoms of digestion in the 7-day period prior to the
visit using the Infant Gastrointestinal Symptoms Questionnaire (time frame: 6 weeks); gastrointestinal
symptoms using the Infant Gastrointestinal Symptoms Questionnaire during the 6-week intervention period
Starting date 27 October 2017
Contact information Name: Wan Wen Tee; Anneke Ravensbergen
Email: wanwen.tee@danone.com; anneke.ravensbergen@danone.com
Telephone: +65 68309466; +65 6830 9419
Notes Status: recruiting
Funding source: Danone Asia Pacific Holdings Pte, Ltd
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D A T A A N D A N A L Y S E S
Comparison 1. Extensively-hydrolysed versus standard formula
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Duration of crying: resolution of
colic
2 64 Risk Ratio (M-H, Random, 95% CI) 2.03 [0.81, 5.10]
2 Duration of crying: resolution of
colic. Sensitivity analysis using
a fixed-effect model
2 64 Risk Ratio (M-H, Fixed, 95% CI) 2.02 [0.96, 4.26]
Analysis 1.1. Comparison 1 Extensively-hydrolysed versus standard formula, Outcome 1 Duration of crying:
resolution of colic.
Review: Dietary modifications for infantile colic
Comparison: 1 Extensively-hydrolysed versus standard formula
Outcome: 1 Duration of crying: resolution of colic
Study or subgroup
Extensively-
hydrolysed Standard formula Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Forsyth 1989 8/11 2/10 39.1 % 3.64 [ 1.00, 13.23 ]
Lucassen 2000 8/23 5/20 60.9 % 1.39 [ 0.54, 3.57 ]
Total (95% CI) 34 30 100.0 % 2.03 [ 0.81, 5.10 ]
Total events: 16 (Extensively-hydrolysed), 7 (Standard formula)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.40, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours standard formula Favours hydrolysed
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Analysis 1.2. Comparison 1 Extensively-hydrolysed versus standard formula, Outcome 2 Duration of crying:
resolution of colic. Sensitivity analysis using a fixed-effect model.
Review: Dietary modifications for infantile colic
Comparison: 1 Extensively-hydrolysed versus standard formula
Outcome: 2 Duration of crying: resolution of colic. Sensitivity analysis using a fixed-effect model
Study or subgroup Hydrolysed Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Forsyth 1989 8/11 2/10 28.1 % 3.64 [ 1.00, 13.23 ]
Lucassen 2000 8/23 5/20 71.9 % 1.39 [ 0.54, 3.57 ]
Total (95% CI) 34 30 100.0 % 2.02 [ 0.96, 4.26 ]
Total events: 16 (Hydrolysed), 7 (Standard)
Heterogeneity: Chi2 = 1.40, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours hydrolysed Favours standard
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library
#1[mh Colic]
#2colic*
#3((stomach or abdominal or abdomen*) near/3 (spasm* or pain* or cramp*))
#4((gastric or gastro*) near/3 (spasm* or pain* or cramp*))
#5[mh Crying]
#6(cry or crying or cries)
#7{or #1-#6}
#8[mh Infant]
#9(baby or babies or child* or infant* or newborn* or neonate*)
#10{or #8-#9}
#11[mh Milk]
#12[mh “Milk, Human”]
#13[mh “Breast Feeding”]
#14(breastfeed* or “breast feed*” or breastfed or “breast fed” or breastmilk* or “breast milk*” or milk*)
#15[mh ˆHypersensitivity]
#16[mh “Food Hypersensitivity”]
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#17[mh Âllergens]
#18[mh “Lactose Intolerance”]
#19(allerg* or hypoallerg* or hypo next allerg* or hyperallerg* or hyper next allerg* or hypersensitiv* or hyper next sensitiv* or intoleran*
or non next allerg* or nonallerg* or sensitiv*)
#20[mh “Infant Food”]
#21(formula* or bottle next fed* or bottlefed* or bottlefeed* or bottle next feed*)
#22[mh Hydrolysis]
#23(hydrolys* or hydrolyz*)
#24[mh Prebiotics]
#25[mh ˆ“Amino acids”] 1
#26(amino next acid* or aminoacid* or casein* or fibre* or fiber* or prebiotic* or pre next biotic* or soy* or whey*)
#27[mh “Dietary Proteins”]
#28[mh “diet therapy”/FS]
#29diet*
#30[mh “Dairy Products”]
#31[mh Fishes]
#32[mh Eggs]
#33[mh Gluten]
#34[mh Nuts]
#35(cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yogurt* or yoghurt*)
#36{or #11-#35}
#37#7 and #10 and #36 in Trials
MEDLINE Ovid
1 Colic/
2 colic$.tw.
3 ((stomach or abdominal or abdomen$) adj3 (spasm$ or pain$ or cramp$)).tw.
4 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).tw.
5 crying/
6 (cry or crying or cries).tw.
7 or/1-6
8 exp Infant/
9 (baby or babies or child$ or infant$ or newborn$ or neonate$).tw.
10 8 or 9
11 7 and 10
12 Milk/
13 Milk, Human/
14 Breast Feeding/
15 (breastfe?d$ or breast fe?d$ or breastmilk$ or breast-milk$ or milk$).tw.
16 Hypersensitivity/
17 exp Food Hypersensitivity/
18 Allergens/
19 Lactose Intolerance/
20 (allerg$ or hypoallerg$ or hypo-allerg$ or hyperallerg$ or hyper-allerg$ or hypersensitiv$ or hyper-sensitiv$ or intoleran$ or non-
allerg$ or nonallerg$ or sensitiv$).tw.
21 exp Infant Food/
22 (formula$ or bottle fed$ or bottlefed$ or bottlefeed$ or bottle feed$).tw.
23 Hydrolysis/
24 (hydrolys$ or hydrolyz$).tw.
25 Prebiotics/
26 Amino acids/)
27 (amino acid$ or aminoacid$ or casein$ or fibre$ or fiber$ or prebiotic$ or pre-biotic$ or soy$ or whey$).tw.
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28 exp Dietary Proteins/
29 diet therapy.fs.
30 diet$.tw.
31 exp Dairy Products/
32 exp Eggs/
33 Fishes/
34 Gluten/
35 Nuts/
36 (cheese$ or dairy or egg$ or fish$ or gluten$ or wheat$ or nut$ or peanut$ or lactose$ or yog?urt$).tw.
37 or/12-36
38 11 and 37
39 randomized controlled trial.pt.
40 controlled clinical trial.pt.
41 randomi#ed.ab.
42 placebo$.ab.
43 drug therapy.fs.
44 randomly.ab.
45 trial.ab.
46 groups.ab.
47 or/39-46
48 exp Animals/ not Humans.sh.
49 47 not 48
50 38 and 49
MEDLINE In-Process & Other Non-Indexed Citations Ovid
1 colic$.mp.
2 ((stomach or abdominal or abdomen$) adj3 (spasm$ or pain$ or cramp$)).mp.
3 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).mp.
4 (cry or crying or cries).mp.
5 or/1-4
6 (baby or babies or child$ or infant$ or newborn$ or neonat$).mp.
7 5 and 6
8 (breastfe?d$ or breast fe?d$ or breastmilk$ or breast-milk$ or milk$).mp.
9 (allerg$ or hypoallerg$ or hypo-allerg$ or hyperallerg$ or hyper-allerg$ or hypersensitiv$ or hyper-sensitiv$ or intoleran$ or non-
allerg$ or nonallerg$ or sensitiv$).mp.
10 (formula$ or bottle fed$ or bottlefed$ or bottlefeed$ or bottle feed$).mp.
11 (hydrolys$ or hydrolyz$).mp.
12 (amino acid$ or aminoacid$ or casein$ or fibre$ or fiber$ or prebiotic$ or pre biotic$ or soy$ or whey$).mp.
13 diet$.mp.
14 (cheese$ or dairy or egg$ or fish$ or gluten$ or wheat$ or nut$ or peanut$ or lactose$ or yog?urt$).mp.
15 or/8-14
16 7 and 15
MEDLINE EPub Ahead of Print Ovid
1 colic$.mp.
2 ((stomach or abdominal or abdomen$) adj3 (spasm$ or pain$ or cramp$)).mp.
3 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).mp.
4 (cry or crying or cries).mp.
5 or/1-4
6 (baby or babies or child$ or infant$ or newborn$ or neonat$).mp.
7 5 and 6
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8 (breastfe?d$ or breast fe?d$ or breastmilk$ or breast-milk$ or milk$).mp.
9 (allerg$ or hypoallerg$ or hypo-allerg$ or hyperallerg$ or hyper-allerg$ or hypersensitiv$ or hyper-sensitiv$ or intoleran$ or non-
allerg$ or nonallerg$ or sensitiv$).mp.
10 (formula$ or bottle fed$ or bottlefed$ or bottlefeed$ or bottle feed$).mp.
11 (hydrolys$ or hydrolyz$).mp.
12 (amino acid$ or aminoacid$ or casein$ or fibre$ or fiber$ or prebiotic$ or pre biotic$ or soy$ or whey$).mp.
13 diet$.mp.
14 (cheese$ or dairy or egg$ or fish$ or gluten$ or wheat$ or nut$ or peanut$ or lactose$ or yog?urt$).mp.
15 or/8-14
16 7 and 15
Embase Ovid
1 colic/
2 colic$.tw.
3 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).tw.
4 crying/
5 (cry or crying or cries).tw.
6 or/1-5
7 exp infant/
8 (baby or babies or child$ or infant$ or newborn$ or neonate$).tw.
9 7 or 8
10 6 and 9
11 infantile colic/
12 10 or 11
13 milk/
14 breast milk/
15 breast feeding/
16 (breastfe?d$ or breast fe?d$ or breastmilk$ or breast-milk$ or milk$).tw.
17 hypersensitivity/
18 exp nutritional intolerance/
19 exp allergen/
20 lactose intolerance/
21 (allerg$ or hypoallerg$ or hypo-allerg$ or hyperallerg$ or hyper-allerg$ or hypersensitiv$ or hyper-sensitiv$ or intoleran$ or non-
allerg$ or nonallerg$ or sensitiv$).tw.
22 exp baby food/
23 (formula$ or bottle fed$ or bottlefed$ or bottlefeed$ or bottle feed$).tw.
24 hydrolysis/
25 prebiotic agent/
26 amino acid/
27 (amino acid$ or aminoacid$ or casein$ or fibre$ or fiber$ or prebiotic$ or pre-biotic$ or soy$ or whey$).tw.
28 exp dairy product/
29 protein intake/
30 diet$.tw.
31 egg/
32 fish/
33 exp nut/
34 gluten/
35 gluten free diet/
36 (cheese$ or dairy or egg$ or fish$ or gluten$ or wheat$ or nut$ or peanut$ or lactose$ or yog?urt$).tw.
37 or/13-36
38 12 and 37
39 Randomized controlled trial/
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40 controlled clinical trial/
41 Single blind procedure/
42 Double blind procedure/
43 triple blind procedure/
44 Crossover procedure/
45 (crossover or cross-over).tw.
46 ((singl$ or doubl$ or tripl$ or trebl$) adj1 (blind$ or mask$)).tw.
47 Placebo/
48 placebo.tw.
49 prospective.tw.
50 factorial$.tw.
51 random$.tw.
52 assign$.ab.
53 allocat$.tw.
54 volunteer$.ab.
55 or/39-54
56 38 and 55
CINAHL Plus EBSCOhost (Cumulative Index to Nursing and Allied Health Literature)
S36 S13 AND S35
S35 S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28
OR S29 OR S30 OR S31 OR S32 OR S33 OR S34
S34 (cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yog#urt*)
S33 (MH “Nuts+”)
S32 (MH “Gluten”) OR (MH “Diet, Gluten-Free”)
S31 (MH “Fish”)
S30 (MH “Eggs”)
S29 (MH “Dairy Products+”)
S28 diet*
S27 (MH “Dietary Proteins+”)
S26 (“amino acid*” or aminoacid* or casein* or fibre* or fiber* or prebiotic* or “pre-biotic*” or soy* or whey*)
S25 (MH “Amino Acids”)
S24 (MH “Prebiotics”)
S23 (hydrolys* or hydrolyz*)
S22 (formula* or bottle-fe#d* or bottlefe#d*
S21 (MH “Infant Food+”)
S20 (allerg* or hypoallerg* or hypo-allerg* or hyperallerg* or hyper-allerg* or hypersensitiv* or hyper-sensitiv* or intoleran* or non-
allerg* or nonallerg* or sensitiv *)
S19 (MH “Allergens”)
S18 (MH “Food Hypersensitivity”)
S17 (MH “Milk Hypersensitivity”)
S16 (breastfe#d* OR breast-fe#d* or breastmilk or breast-milk or milk)
S15 (MH “Breast Feeding”)
S14 (MH “Milk, Human”)
S13 S11 OR S12
S12 (MH “Infant Colic”)
S11 S7 AND S10
S10 S8 OR S9
S9 (MH “Infant+”)
S8 TI(baby or babies or child* or infant* or newborn* or neonate*) ORAB(baby or babies or child* or infant* or newborn* or neonate*)
S7 S1 OR S2 OR S3 OR S4 OR S5 OR S6
S6 (cry or crying or cries)
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S5 (MH “Crying”)
S4 ((gastric or gastro*) N3 (spasm* or pain* or cramp*))
S3 ((stomach or abdominal or abdomen*) N3 (spasm* or pain* or cramp*))
S2 colic*
S1 (MH “Colic”)
PsycINFO Ovid
1 crying/
2 colic$.tw.
3 (cry or crying or cries).tw.
4 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).tw.
5 ((stomach or abdominal or abdomen$) adj3 (spasm$ or pain$ or cramp$)).tw.
6 or/1-5
7 (baby or babies or child$ or infant$ or newborn$ or neonate$).tw.
8 (infancy 2 23 mo or neonatal birth 1 mo).ag.
9 7 or 8
10 breast feeding/
11 (breastfe?d$ or breast fe?d$ or breastmilk$ or breast-milk$ or milk$).tw.
12 bottle feeding/
13 Food Allergies/
14 antigens/
15 (allerg$ or hypoallerg$ or hypo-allerg$ or hyperallerg$ or hyper-allerg$ or hypersensitiv$ or hyper-sensitiv$ or intoleran$ or non-
allerg$ or nonallerg$ or sensitiv$).tw.
16 (formula$ or bottle fed$ or bottlefed$ or bottlefeed$ or bottle feed$).tw.
17 (hydrolys$ or hydrolyz$).tw.
18 dietary supplements/
19 (amino acid$ or aminoacid$ or casein$ or fibre$ or fiber$ or prebiotic$ or pre-biotic$ or soy$ or whey$).tw.
20 Amino acids/
21 diet$.tw.
22 (cheese$ or dairy or egg$ or fish$ or gluten$ or wheat$ or nut$ or peanut$ or lactose$ or yog?urt$).tw.
23 or/10-22
24 6 and 9 and 23
25 clinical trials/
26 random$.tw.
27 (allocat$ or assign$).tw.
28 ((clinic$ or control$) adj trial$).tw.
29 ((control$ or experiment$ or intervention$) adj3 group$).tw.
30 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
31 (crossover$ or “cross over$”).tw.
32 random sampling/
33 Experiment Controls/
34 Placebo/
35 placebo$.tw.
36 exp program evaluation/
37 treatment effectiveness evaluation/
38 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.
39 or/25-38
40 24 and 39
Science Citation Index (SCI) and Social Sciences Citation Index (SSCI); Web of Science
# 12 #11 AND #10
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# 11 TS=(random* or control* or trial* or placebo* or group* or blind* or double-blind*) .
# 10 #9 AND #1
# 9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2
# 8 TS= (cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yog*urt*)
# 7 TS=(hydrolys* or hydrolyz*)
# 6 TS=(“amino acid*” or aminoacid* or casein* or fibre* or fiber* or prebiotic* or pre-biotic* or soy* or whey*)
# 5 TS= (allerg* or hypoallerg* or hypo-allerg* or hyperallerg* or hyper-allerg* or hypersensitiv* or hyper-sensitiv* or intoleran* or
non-allerg* or nonallerg* or sensitiv *)
# 4 TS=(formula* or bottle-fed or bottle-feed* or bottlefeed* or bottlefed)
# 3 TS=(breastfed or breast-fed or breastfeed* or breast-feed* )
# 2 TS=(diet*)
#1 TS=((colic* or crying or cries or cry) Near/10 (infant* or baby or babies or child*))
Conference Proceedings Citation Index - Science (CPCI-S) and Conference Proceedings Citation Index -
Social Science & Humanities (CPCI-SS&H); Web of Science
#10 #9 AND #1
#9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2
#8 TS= (cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yog*urt*)
#7 TS=(hydrolys* or hydrolyz*)
#6 TS=(“amino acid*” or aminoacid* or casein* or fibre* or fiber* or prebiotic* or pre-biotic* or soy* or whey*)
#5 TS= (allerg* or hypoallerg* or hypo-allerg* or hyperallerg* or hyper-allerg* or hypersensitiv* or hyper-sensitiv* or intoleran* or non-
allerg* or nonallerg* or sensitiv *)
#4 TS=(formula* or bottle-fed or bottle-feed* or bottlefeed* or bottlefed)
#3 TS=(breastfed or breast-fed or breastfeed* or breast-feed* )
#2 TS=(diet*)
#1 TS=((colic* or crying or cries or cry) Near/10 (infant* or baby or babies or child*))
Cochrane Database of Systematic Reviews (CDSR), part of the Cochrane Library
#1[mh Colic]
#2colic*:ti,ab
#3[mh Crying]
#4(cry or crying or cries):ti,ab
#5{or #1-#4}
#6[mh Infant]
#7(baby or babies or child* or infant* or newborn* or neonate*):ti,ab
#8{or #6-#7}
#9#5 and #8
#10[mh Milk]
#11[mh “Milk, Human”]
#12[mh “Breast Feeding”]
#13(breastfeed* or “breast feed*” or breastfed or “breast fed” or breastmilk* or “breast milk*” or milk*):ti,ab
#14[mh ˆHypersensitivity]
#15[mh “Food Hypersensitivity”]
#16[mh Âllergens]
#17[mh “Lactose Intolerance”]
#18(allerg* or hypoallerg* or hypo next allerg* or hyperallerg* or hyper next allerg* or hypersensitiv* or hyper next sensitiv* or intoleran*
or non next allerg* or nonallerg* or sensitiv*):ti,ab
#19[mh “Infant Food”]
#20(formula* or bottle next fed* or bottlefed* or bottlefeed* or bottle next feed*):ti,ab
#21[mh Hydrolysis]
#22(hydrolys* or hydrolyz*):ti,ab
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#23[mh Prebiotics]
#24[mh ˆ“Amino acids”]
#25(amino next acid* or aminoacid* or casein* or fibre* or fiber* or prebiotic* or pre next biotic* or soy* or whey*):ti,ab
#26[mh “Dietary Proteins”]
#27[mh “diet therapy”/FS]
#28diet*:ti,ab
#29[mh “Dairy Products”]
#30[mh Fishes]
#31[mh Eggs]
#32[mh Gluten]
#33[mh Nuts]
#34(cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yogurt* or yoghurt*):ti,ab
#35{or #10-#34}
#36 #9 and #35 in Cochrane Reviews (Reviews and Protocols)
Database of Abstracts of Reviews of Effects (DARE), part of the Cochrane Library
#1[mh Colic]
#2colic*:ti,ab
#3[mh Crying]
#4(cry or crying or cries):ti,ab
#5{or #1-#4}
#6[mh Infant]
#7(baby or babies or child* or infant* or newborn* or neonate*):ti,ab
#8{or #6-#7}
#9#5 and #8
#10[mh Milk]
#11[mh “Milk, Human”]
#12[mh “Breast Feeding”]
#13(breastfeed* or “breast feed*” or breastfed or “breast fed” or breastmilk* or “breast milk*” or milk*):ti,ab
#14[mh ˆHypersensitivity]
#15[mh “Food Hypersensitivity”]
#16[mh Âllergens]
#17[mh “Lactose Intolerance”]
#18(allerg* or hypoallerg* or hypo next allerg* or hyperallerg* or hyper next allerg* or hypersensitiv* or hyper next sensitiv* or intoleran*
or non next allerg* or nonallerg* or sensitiv*):ti,ab
#19[mh “Infant Food”]
#20(formula* or bottle next fed* or bottlefed* or bottlefeed* or bottle next feed*):ti,ab
#21[mh Hydrolysis]
#22(hydrolys* or hydrolyz*):ti,ab
#23[mh Prebiotics]
#24[mh ˆ“Amino acids”]
#25(amino next acid* or aminoacid* or casein* or fibre* or fiber* or prebiotic* or pre next biotic* or soy* or whey*):ti,ab
#26[mh “Dietary Proteins”]
#27[mh “diet therapy”/FS]
#28diet*:ti,ab
#29[mh “Dairy Products”]
#30[mh Fishes]
#31[mh Eggs]
#32[mh Gluten]
#33[mh Nuts]
#34(cheese* or dairy or egg* or fish* or gluten* or wheat* or nut* or peanut* or lactose* or yogurt* or yoghurt*):ti,ab
#35{or #10-#34}
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#36#9 and #35 in Other Reviews
LILACS (Latin American and Caribbean Health Science Information Database;
search.bvsalud.org/portal/?lang=en)
tw:((colic* OR cries OR crying OR cry) AND (infant* OR newborn* OR neonate* OR baby OR babies OR child*)) AND (instance:
“regional”) AND ( db:(“LILACS”) AND type˙of˙study:(“clinical˙trials”))
IBECS (search.bvsalud.org/portal/?lang=en)
(tw:(colic* OR cries OR crying OR cry)) AND (tw:(infant* OR newborn* OR neonate* OR baby OR babies OR child*)) AND
(instance:“regional”) AND ( db:(“IBECS”)) AND (instance:“regional”) AND ( type˙of˙study: (“clinical˙trials”))
HomeoIndex (bases.bireme.br/cgi-bin/wxislind.exe/iah/online)
Search on : colic$ or cry$ or cries [Words] and infant$ [Words]
Networked Digital Library of Theses and Dissertations (NDLTD; www.ndltd.org)
infant* AND colic AND random*
TROVE (limited to Australian theses; trove.nla.gov.au)
Keyword: Any of the words: infant* babies
Keyword: Any of the words: colic* crying
Keyword: Any of the words: random* placebo* control* blind* group*
Limited to Books Format: Thesis
WorldCat OCLC (limited to theses; www.worldcat.org)
(ti:infant* OR babies) AND (kw:colic* OR crying) AND (kw:random* OR trial* OR control* OR blind*)
PubMed Diet Supplement subgroup (ods.od.nih.gov/Research/PubMed˙Dietary˙Supplement˙Subset.aspx)
#26 (#22 and #25) Filters: Dietary Supplements
#25 (#23 or #24) Filters: Dietary Supplements
#24 (baby [tiab] or babies [tiab] or child* [tiab] or infant [tiab] or newborn [tiab] or neonate [tiab]) Filters: Dietary Supplements
#23 infant [mh] Filters: Dietary Supplements
#22 (#9 and #21) Filters: Dietary Supplements
#21 (#18 NOT #20) Filters: Dietary Supplements
#20 ((animals [mh] NOT humans [mh])) Filters: Dietary Supplements
#18 (#10 or #11 or #12 or #13 or #14 or #15 or #16 or #17) Filters: Dietary Supplements
#17 groups [tiab] Filters: Dietary Supplements
#16 trial [tiab] Filters: Dietary Supplements
#15 randomly [tiab] Filters: Dietary Supplements
#14 drug therapy [sh] Filters: Dietary Supplements
#13 placebo [tiab] Filters: Dietary Supplements
#12 randomized [tiab] Filters: Dietary Supplements
#11 controlled clinical trial [pt] Filters: Dietary Supplements
#10 randomized controlled trial [pt] Filters: Dietary Supplements
#9 (#1 or #2 or #5 or #6 or #7 or #8) Filters: Dietary Supplements
#8 (crying[tiab] or cry [tiab] or cries [tiab]) Filters: Dietary Supplements
#7 crying [mh] Filters: Dietary Supplements
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#6 ((spasm* [tiab] or pain* [tiab] or cramp* [tiab])) AND (gastro* [tiab] or gastric[tiab]) Filters: Dietary Supplements
#5 (((spasm* [tiab] or pain* [tiab] or cramp* [tiab]))) AND ((stomach[tiab] or abdominal [tiab] or abdomen* [tiab]) Filters: Dietary
Supplements
#2 colic* [tiab] Filters: Dietary Supplements
#1 colic [mh] Filters: Dietary Supplements
ClinicalTrials.gov (clinicaltrials.gov)
infant colic AND Study type= intervention
World Health Organization International Clinical Trials Registry Platform (WHO ICTRP;
apps.who.int/trialsearch)
Basic search infant* AND crying OR infant* AND cries OR infant* AND colic*
Appendix 2. ’Risk of bias’ criteria and judgements
Sequence generation for randomisation
We included only RCTs or quasi-RCTs in this review. We assessed randomisation at low risk of bias if the procedure of sequence
generation was explicitly described. Examples include computer-generated random numbers, a random numbers table or coin-tossing.
Where no description was given, we contacted the study authors for further information, and where we failed to receive a response,
we assigned a judgment of unclear risk of bias. We considered studies to be at high risk of bias when reporting methods that were not
random.
Allocation concealment
We assessed concealment of treatment allocation at low risk of bias if the procedure was explicitly described and adequate efforts were
made to ensure that intervention allocations could not have been foreseen in advance of, or during, enrolment. Examples include
centralised randomisation, numbered or coded containers, or sealed envelopes. We considered the following procedures to have a high
risk of bias: alternation, or reference to case record numbers or dates of birth. Where no description was given, we contacted the study
authors and, if we did not receive a response, we assigned a judgment of unclear risk of bias.
Blinding of parents and health professionals
In this context, the intervention is administered by parents and so, in effect, we considered them to be the target of the blinding
procedures. Indeed, as the participants were less than four months of age by the defined inclusion criteria (Criteria for considering
studies for this review), we deemed that this item was not applicable to them. Furthermore, parents often act as outcome assessors. We
primarily assessed the risk of bias associated with the blinding of participants based on the likelihood that such blinding was sufficient
to ensure that parents had no knowledge as to which intervention the infant received. We assessed blinding at low risk of bias where
it was explicitly described how the parents could have no knowledge of which intervention the infant was receiving, and at high risk
of bias where it was clear that parents were aware of which intervention the infant was receiving. We assessed blinding at unclear risk
of bias where we did not have enough information to make an assessment of either high or low risk of bias, based on the information
provided in the papers, or after contacting the study authors.
Blinding of outcome assessment
For each included study we described the methods used, if any, to blind the outcome assessors from knowledge of which intervention
a participant received. We judged studies at low risk of bias if they were blinded, or if we considered that the lack of blinding could
not have affected the results. If blinding was not possible because of the nature of intervention, we judged the study at high risk of bias
since it is possible that the lack of blinding influenced the results. We noted the blinding of health professionals where reported. Where
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no description was given, we contacted the study authors for more information, and where we did not receive a response, we assigned
a judgment of unclear risk of bias.
Incomplete outcome data
Incomplete outcome data essentially include attrition, exclusions, and missing data.
We assigned a judgment of low risk of bias if:
1. participants included in the analysis were exactly those who were randomized into the trial, if missing outcome data were
balanced in terms of numbers across intervention groups, with similar reasons for missing data across groups, or if there were no
missing outcome data;
2. for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk was not sufficient to
have a clinically relevant impact on the intervention effect estimate;
3. for continuous outcome data, the plausible effect size (SMD) among missing outcomes was not sufficient to have a clinically
relevant impact on observed effect size; or
4. missing data were imputed using appropriate methods.
We assigned a judgment of high risk of bias:
1. when reasons for missing outcome data were likely to be related to the true outcome, with either an imbalance in numbers or
reasons for missing data across intervention groups;
2. for dichotomous outcome data, when the proportion of missing outcomes compared with observed event risk was sufficient to
induce clinically relevant bias in the intervention effect estimate;
3. for continuous outcome data, when the plausible effect size (SMD) among missing outcomes was sufficient to induce clinically
relevant bias in the observed effect size;
4. when an ’as-treated’ analysis was carried out in cases where there was substantial departure of the intervention received from that
assigned at randomisation; or
5. when there was a potentially inappropriate application of simple imputation.
We assigned a judgment of unclear risk of bias:
1. when there was insufficient reporting of attrition or exclusions (or both) to permit a judgment of low or high risk of bias;
2. if the study reported incomplete outcome data; or
3. if the numbers randomized to intervention and control groups were not clearly reported.
Selective outcome reporting
We assessed the reporting of outcomes at low risk of bias if all study outcomes declared in the Methods section were reported in the
Results section. We also evaluated whether different reports of the study were available, including protocols, and examined them to
ensure there was no suggestion of selective outcome reporting. Where no description was given, we contacted the study authors for
more information, and where no response was received, we assigned a judgment of unclear risk of bias. Where there was evidence of
selective outcome reporting, we assigned a judgment of high risk of bias.
Other potential threats to validity
Where a study was at risk of other sources of bias, we assessed it at high risk of bias. For instance, sources of sponsorship or funding
constitute one common example of a factor which may pose a risk of bias. We assessed each study at low risk of bias if it appeared to
be free from such threats to validity. Where the risk of bias was unclear from the published information, we attempted to contact the
study authors for clarification. Where this information was not forthcoming, we assessed these studies at unclear risk of bias.
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Miriam Sorrenti wrote the protocol and the Discussion section of the review.
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Lorenzo Moja provided statistical advice and revised key sections of the review.
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data, and wrote the review.
Simone Ceratto wrote the Discussion section and contributed to the write-up of the Results section of the review.
Francesco Savino has primary responsibility for the review. He co-ordinated the efforts of the review authors. He wrote the protocol
and contributed to the write-up of the Results and Discussion sections of the review.
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from Allergan, Ferring Pharmaceuticals, Biogaia, Synergy and Tillots, to attend conferences (Advances in Inflammatory Bowel Disease,
Digestive Disease Week, World Congress of Gastroentrology) and present the results of other Cochrane Reviews. These companies
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this work. MG is a paediatrician with an interest in gastroenterology. This involves seeing patients referred with infantile colic and
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S O U R C E S O F S U P P O R T
Internal sources
• Department of Pediatrics, Regina Margherita Children’s Hospital, Città della Salute e della Scienza, Turin, Italy.
Logistical support
External sources
• None, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Please see our protocol (Savino 2014).
Authors
Valentina Tarasco left the review team and was replaced by Shel Banks and Simone Ceratto.
Morris Gordon took over as lead author.
Types of outcome measures
We reworded the outcomes of ’reduction in the duration of crying’ and ’reduction in frequency of crying episodes per 24 h, to the
following more neutral formulations, to reflect the fact that we are assessing the variable rather than a reduction in the variable: ’duration
of crying’ and ’frequency of crying episodes per 24 h’.
We planned on defining responders as a 50% reduction in crying. However, the peer reviewers raised questions as to the external basis
for this decision, so we decided to revert to a more standard definition of ’responders’, as defined by primary studies. As no study
reported outcomes in this area with utility for analysis, this did not impact the analysis or findings.
We planned further analyses according to each specific adverse effect when the primary studies provided sufficient data. However, we
did not complete this analysis as such data were not presented, with adverse effects rarely encountered.
In addition, we included the outcome ’parental satisfaction’ in Summary of findings for the main comparison, but this was not in our
protocol (Savino 2014). We modified the Methods sections accordingly.
See Types of outcome measures.
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Search methods for identification of studies
In order to ensure our search was as up-to-date as possible, we searched two additional databases, which are updated daily (Ovid
MEDLINE In-Process & Other Non-Indexed Citations and Ovid MEDLINE Epub Ahead of Print). See Electronic searches.
Selection of studies
We clarified that we excluded stand-alone abstracts from this review. Given the extreme complexity of the studies found, including
issues of heterogeneity of specific interventions, patient characteristics and outcomes reported, as well as the poor quality of the abstracts
found within the search, the team decided not to consider abstracts unless they related to a study for which we also had a full-text
report. See Selection of studies.
Measures of treatment effect: continuous data
To analyse continuous data, we planned to use, according to need, either change scores or final values without combining them.
However, no such analysis was possible due to a lack of data.
Had both continuous and dichotomous data been available for an outcome, we planned to include only the continuous outcome in the
primary analysis. We planned that when studies had reported an outcome as a dichotomous measure, and others had used a continuous
measure of the same construct, to convert the results for the former from the dichotomous measure to a standardised mean difference,
provided that we could assume the underlying continuous measure had an approximately normal or logistic distribution (otherwise we
would have carried out two separate analyses). However, no such analysis was possible due to a lack of data. See Measures of treatment
effect.
Unit of analysis issues
Studies with multiple treatment arms
Had our strategy to combine data to make single, pair-wise comparisons prevented investigation of potential sources of heterogeneity,
we planned to analyse each formula separately (against a common control group - placebo), but divide the sample size for common
comparator arms proportionately across each comparison (Higgins 2011b). This simple approach allows the use of standard software
(including RevMan 2014), and prevents the inappropriate double-counting of individuals; however, it was not needed due to a lack of
data. Additionally, concerns with the length of a reasonable washout period existed and further limited scope for such analysis.
Cross-over studies
For cross-over trials, we planned to used the mean and standard error of the paired analysis for the meta-analysis; however, this was
not possible due to a lack of data. In future updates of this review, should we have sufficient data, we will include both parallel and
cross-over studies with an adequate washout period in a meta-analysis using the inverse variance method, as recommended by Elbourne
2002; in the meta-analysis, the weight of each study is inversely proportional to the variance (one over the square of the standard error)
(Deeks 2017). We will include cross-over studies with an inadequate washout period in a meta-analysis using the data from the first
arm only. Even though this method excludes some of the data, it avoids the inappropriate consideration of correlated information.
See Unit of analysis issues.
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Data synthesis
We included a new section on ’Assessment of the quality of the evidence’ at the request of the editorial base. See Data synthesis.
Additional references
We updated our references to the latest versions of Chapters 8, Higgins 2017, and 9, Deeks 2017, in theCochrane Handbook for
Systematic Reviews of Interventions.
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